Gene Regulation by Metabolic Enzyme GMP Synthetase and Chromatin Remodeler NuRD by Reddy, A.B.A. (Ashok)

Gene Regulation by Metabolic Enzyme GMP Synthetase 
and Chromatin Remodeler NuRD
Ashok Bandi Adinarayana Reddy
23989 Ashok Reddy.indd   1 04-12-12   17:13
Colofon
ISBN 978-90-6464-621-8
© 2012 Ashok Bandi Adinarayana Reddy
Design cover Ashok Reddy and Praveen S.Y
Lay-out: Ferdinand van Nispen, Citroenvlinder-dtp.nl, Bilthoven (Nl)
Print: GVO | Ponsen & Looijen, Ede
23989 Ashok Reddy.indd   2 04-12-12   17:13
Gene Regulation by Metabolic Enzyme GMP 
Synthetase and Chromatin Remodeler NuRD
Genregulatie door Metabolische Enzymen GMP Synthetase  
en Chromatine Remodelleerder NuRD
Proefschrift
Ter verkrijging van de graad van doctor aan de
Erasmus Universiteit Rotterdam
op gezag van de rector magnificus
Prof. dr. H.G. Schmidt
en volgens besluit van het College voor Promoties.
De openbare verdediging zal plaatsvinden op
Woensdag 19 December 2012 om 11.30 uur
Door
Ashok Bandi Adinarayana Reddy
Geboren te Manchenahalli, INDIA
23989 Ashok Reddy.indd   3 04-12-12   17:13
Promotiecomissie:
Promotoren:  Prof. dr. C.P. Verrijzer
Overige leden: Prof. dr. J.N.J. Philipsen
  Prof. dr. ir. D.N. Meijer
  Prof. dr. R. Fodde
                              
  
 
The studies described in this thesis were performed in the Department of 
Biochemistry, Erasmus MC, Rotterdam
23989 Ashok Reddy.indd   4 04-12-12   17:13
Table of Contents
Scope of the Thesis 7
Chapter 1 Introduction 9
Chapter 2 Metabolic Enzyme GMP Synthetase is a TRIM21-controled 
Relay of Stress-induced Stabilization of p53
31
Chapter 3: Drosophila Transcription Factor Tramtrack69 Binds to MEP1 
to Recruit Chromatin Remodeler NuRD
55
Chapter 4 Gene Regulation by Tumor Suppressor DOC1 71
Chapter 5 General Discussion 83
Summary 91
Nederlandse Samenvatting 93
PhD portfolio 95
Curriculum vitae 96
Acknowledgements 98
  
23989 Ashok Reddy.indd   5 04-12-12   17:13
23989 Ashok Reddy.indd   6 04-12-12   17:13
7Scope of the Thesis
Spatial and temporal control of the gene expression is crucial for normal growth and 
development of an organism. Environmental stress factors pose a constant threat 
to normal development of an organism by causing altered gene expression. Cells 
have evolved counteractive mechanisms to overcome the stress caused by external 
factors. Among these, stabilization of p53 is the major stress responsive pathway. 
In response to diverse cellular insults including DNA damage, p53 gets stabilized 
and regulates the expression of genes that induce cell cycle arrest, senescence, and 
apoptosis. However, it is unclear how p53 is stabilized upon cellular stress. Chapter 
2 describes the identification of nucleotide biosynthetic enzyme GMPS and E3 
ubiquitin-ligase TRIM21, as key players in regulation of p53 stability. Upon cellular 
stress, GMPS stabilizes p53 through USP7-mediated deubiquitylation. GMPS acts 
as a sensor of the nucleotide pool in the cell and activates p53-mediated replicative 
stress response to the nucleotides depletion. Thus, GMPS ensures the error free 
cell divisions by coordinating nucleotide synthesis and p53-mediated cell cycle 
regulation. TRIM21 negatively regulates p53 stability and function by targeting 
GMPS to cytoplasm. Since loss of p53 function is reported in more than 50% of 
human cancers targeting TRIM21 might serve as a therapeutic opportunity for 
cancer treatment. 
Combination of transcription factors and specialized chromatin 
remodeling machines ensure tight control of gene expression. Chapter 3 describes 
the combinatorial role of the transcription factor TTK69 and the chromatin 
remodeler NuRD complex in gene regulation. TTK69 is a transcriptional repressor 
of the neuronal cell fate in Drosophila. However, how exactly TTK69 represses its 
target genes still largely unknown. In this study we identified drosophila MEP1 as a 
bona fide subunit of the NuRD complex. Biochemical and genetic assays establish 
that TTK69 binds to MEP1 to recruit the NuRD complex for the transcriptional 
repression of its target genes. In addition, we also identified the fly homolog of 
human Deleted in Oral Cancer 1 (DOC1) also known as CDK2-Associated Protein 
1 (CDK2AP1) as a bona fide NuRD subunit. DOC1 is a potential tumor suppressor 
that is found deleted or down regulated in many cancers including oral cancer. 
Chapter 4 addresses the role of human DOC1 in gene regulation. By proteomics 
analysis and functional assays, we establish that DOC1-NuRD complex inhibits the 
expression of TGF-b target genes those promote tumorigenesis. In this thesis, we 
identified GMPS and TRIM21 as key players in control of tumor suppressor p53 
pathway and dMEP1 and DOC1 as bona fide subunits of the NuRD complex and 
their gene regulation networks in Drosophila development and cancer. 
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Chromatin structure and dynamics
In eukaryotes, DNA is packed into highly organized nucleoprotein complexes called 
Chromatin. Approximately 146 bp of the DNA is wrapped two times around an 
octamer of histones, H2A, H2B, H3 and H4. This is the fundamental repeating unit of 
eukaryotic chromatin structure, referred to as Nucleosome (Kornberg, 1977; Luger et 
al., 1997). Positively charged amino acid residues in histones contact the negatively 
charged phosphate backbone of DNA to form a stable nucleosome structure. The 
adjoining nucleosomes with linker DNA appear as structures similar to ‘beads on 
a string’. With the addition of linker histone H1, ‘beads on a string’ structures coils 
into higher order structures ranging from 30 nm chromatin filaments to highly 
condensed mitotic chromosomes, see Figure 1 (Li and Reinberg, 2011). Positioning 
of the nucleosomes along the DNA is determined by several factors, such as intrinsic 
DNA sequence properties, DNA binding proteins or transcription machinery and 
ATP-dependent chromatin remodeling complexes (Segal et al., 2006). Chromatin 
is largely divided into euchromatin and heterochromatin based on nucleosome 
density. Euchromatin is lightly packed where DNA is accessible to the transcription 
machinery and other chromatin regulators, whereas heterochromatin is tightly 
packed and not accessible to chromatin regulators and often associated with gene 
silencing (Simonis et al., 2006). Thus, nucleosomes act as a barrier for the factors 
that mediate DNA-dependent processes such as transcription, DNA replication, 
repair and recombination. Despite being rigid in its structure, chromatin is found 
to be remarkably dynamic. The dynamic chromatin structure is regulated by DNA 
packing proteins, such as histones and non-histone proteins, non-coding RNA, 
factors that mediate histone deposition and removal, histone modifying enzymes 
and a group of chromatin remodeling complexes.
Gene regulation by posttranslational modification of proteins
Histone modifiers directly add or remove posttranslational modifications to various 
amino acids in the histones. Lysine (K) residues are the target for acetylation, 
methylation, ubiquitylation or sumoylation whereas Arginines (R) can be either 
mono- or di-methylated. Serine (S) and Threonine (T) residues get phosphorylated 
(Strahl and Allis, 2000; Suganuma and Workman, 2011). The negatively charged 
acetyl moiety has been shown to disrupt the histone-DNA contacts, resulting 
in an open chromatin structure. Removal of acetylation on histones results in 
stabilization of histone-DNA contacts and a compact chromatin structure (Cheung 
et al., 2000). Unlike acetylation which disrupts histone-DNA contacts, methylation 
acts as a docking site for the chromatin regulatory proteins. Histone methylation 
is associated with either active or repressive chromatin states (Rea et al., 2000). 
Sumoylation of histones acts as a docking site for sumo-binding proteins and is 
implicated in transcriptional repression (Shiio and Eisenman, 2003; Yang and 
Sharrocks, 2004). Histone phosphorylation is linked to transcription regulation and 
23989 Ashok Reddy.indd   10 04-12-12   17:13
11
IntroductIon
1
signalling (Berger, 2010). Phosphorylation at H3, S10 marks the mitotic stage of 
the cell cycle (Hsu et al., 2000). Similar to the histones, DNA also gets modified by 
methylation at cytosine residues. DNA methylation at gene promoters results in 
repression of the gene expression. DNA methylation also acts as a docking site for 
the methyl-DNA binding proteins, which are often associated with transcriptional 
repression and heterochromatin formation. (Jenuwein and Allis, 2001; Shilatifard, 
2006; Strahl and Allis, 2000; Suganuma and Workman, 2011). 
Figure 1; Schematic representation of different levels of chromatin organization (adopted 
from, http://micro.magnet.fsu.edu/cells/nucleus/chromatin.html)
Histone ubiquitylation is implicated in transcription regulation and DNA 
repair. Histone H2A and H2B has been shown to be monoubiquitylated (Shiloh 
et al., 2011; Wright et al., 2012). Ubiquitylation is a reversible post-translational 
modification that regulates stability, localization or function of a target protein. 
Protein ubiquitylation is a multi-step enzymatic process, wherein ubiquitin is 
conjugated to the lysine residues of a target protein by an E3 ubiquitin-ligase that is 
highly substrate-specific. In general, monoubiquitylation acts as a signal for protein 
localization, gene expression control or endocytosis. Polyubiquitylation, where in 
ubiquitin is linked by Lysine 48 (K48) is a signal for proteasome-mediated degradation 
of the target protein. K11-, K29- and K63-linked polyubiquitin acts as a signal for DNA 
damage response, kinase activation and vesicle trafficking, see Figure 2 (Hershko and 
Ciechanover, 1998; Komander and Rape, 2012; Schlesinger and Goldstein, 1975). 
Ubiquitylation plays a crucial role in gene regulation not only through the direct 
modulation of gene expression by histone ubiquitylation but also by indirectly 
controlling stability and localization of transcription factors. Here, we discuss in detail 
the regulation of gene expression and transcription factor stability and localization 
by ubiquitylation-dependent mechanisms involving the metabolic enzyme GMP 
synthetase, the deubiquitinase USP7 and the E3 ubiquitin-ligase TRIM21.
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Figure 2; Overview of ubiquitin signalling; Ubiquitylation is a multistep enzymatic process 
wherein ubiquitin is ligated to the lysine residue of the target protein. In an activation step 
ubiquitin is transferred to enzyme E1 in an ATP-dependent manner. Next, in the conjugation 
step, ubiquitin is transferred to E2 enzyme. The E2 carries ubiquitin to E3 enzymes, also 
called ubiquitin-ligases. E3 ubiquitin-ligases covalently ligate ubiquitin to a lysine residue of 
the specific protein substrate. Transfer of multiple ubiquitin to the same lysine leads to 
polyubiquitylation. Ligation of polyubiquitylation has a specific effect on the target protein. 
For example, K48-linked polyubiquitin is a signal for the proteasome-mediated degradation 
of the target protein. K11-, K29- and K48-linked polyubiquitin acts as a signal for DNA 
damage response, kinase activation and vesical trafficking.  Monoubiquitylation or multi-
monoubiquitylation serves as a signal for protein targeting by sub-cellular localization, 
endocytosis and gene regulation (Komander and Rape, 2012).  
Guanine monophosphate synthetase (GMP synthetase) 
GMP synthetase (EC 6.3.5.2) also known as GMPS, is a glutamine amidotransferase 
that catalyses the conversion of XMP to GMP, the final reaction in purine nucleotide 
biosynthesis in the de novo pathway, see Scheme 1B. GMPS contains N-terminal 
glutamine amidotransferase (GAT) domain with Cys-His-Glu as a catalytic triad for 
glutamine hydrolysis. The central ATP pyrophosphate (ATPP) domain is responsible 
for binding XMP and ATP, and catalyses the formation of O2-adenyl-XMP and PPi. 
The C-terminal dimerization domain (CTD) is essential for protein oligomerization, 
see Scheme 1A (Tesmer et al., 1996). The end products of purine metabolism such 
as AMP and GMP play a vital role in metabolic regulation and DNA biosynthesis. 
AMP and GMP are the precursors of ATP and GTP respectively, and are essential 
for DNA synthesis. Cyclic-AMP and cyclic-GMP act as secondary messengers 
and activate different protein kinases involved in cellular metabolism. Elevated 
levels of nucleotide biosynthetic enzymes were observed in rapidly growing 
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tissues and tumours. Therefore, nucleotide biosynthetic enzymes are considered 
prime targets for drug design for cancer (Weber, 1983). In contrast, a recent 
report suggests that nucleotide deficiency is the prime cause for the initiation 
of tumorigenesis. Oncogenic signals trigger cell proliferation without coordinate 
increase in nucleotide synthesis resulting in aberrant DNA replication and damage, 
contributing to carcinogenesis (Bester et al., 2011). Thus, nucleotide biosynthetic 
enzymes play a crucial role in the regulation of cell division by supplying nucleotides 
for error free DNA synthesis. 
GAT
1 249 548 693
ATPP CTDGMPS
A)
B)
Scheme 1; A) Domain organisation of GMPS, GAT; glutamine amidotransferase domain, 
ATPP; ATP pyrophosphate domain and CTD; C-terminal dimerization domain
B) Schematic overview of the de novo purine nucleotide biosynthetic pathway. The end 
products are AMP and GMP. (adopted from, http://themedicalbiochemistrypage.org/
nucleotide-metabolism.php)
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In addition to functioning as a nucleotide synthetic enzyme, GMPS is 
also found in complex with the deubiquitinase Ubiquitin Specific Protease 7 (USP7) 
in Drosophila (van der Knaap et al., 2005) and in mammalian cells (Sarkari et al., 
2009). GMPS has been shown to stimulate the histone H2B deubiquitinase activity 
of USP7, a mechanism that is independent of GMPS nucleotide synthesis activity. 
Monoubiquitylation of histone H2A and H2B are implicated in gene expression 
regulation. In general, monoubiquitylation of histone H2B is associated with gene 
activation, whereas monoubiquitylation of H2A is associated with gene silencing. 
Therefore, GMPS/USP7, a histone H2B deubiquitinase complex, is implicated in the 
transcriptional repression of polycomb-responsive elements, ecdysone inducible 
genes and Epstein barr virus latent origin of replication (Frappier and Verrijzer, 
2011; Sarkari et al., 2009; van der Knaap et al., 2010; van der Knaap et al., 2005).
Ubiquitin Specific Protease 7 (USP7)
USP7 also known as HAUSP and was originally identified as a binding partner of 
PML in nuclear bodies, herpes-simplex viral proteins, ICP0 (infected cell protein 
0) and EBNA1 (Epstein-Barr nuclear antigen 1) (Everett et al., 1997b; Holowaty et 
al., 2003b; Meredith et al., 1994). USP7 structurally consists of an N-terminal TRAF 
domain, a central catalytic domain (CD) and a C-terminal ubiquitin like (Ubl) domain 
(Figure 3A). TRAF is a protein-protein interaction domain, CD is responsible for the 
deubiquitylation of proteins and the Ubl domain is essential for the regulation of 
USP7 catalytic activity (Faesen et al., 2012; Holowaty et al., 2003a). GMPS has been 
shown to activate USP7 catalytic activity by allosterically binding to the Ubl domain. 
USP7 consists of five Ubl’s, Ubl4 and 5 are essential for activation of its catalytic 
activity. GMPS binds to Ubl1-3 and stimulates USP7 catalytic activity by stabilizing 
the Ubl4-5 dependent active state (Faesen et al., 2011). USP7 is implicated in the 
regulation of tumor suppressor p53 and E3 ubiquitin-ligase MDM2 stability by de-
ubiquitylation (Cummins et al., 2004; Li et al., 2002). p53 and MDM2 competitively 
bind to the TRAF domain of USP7, MDM2 binds with a higher affinity to USP7 than 
p53 (Sheng et al., 2006). Death domain-associated protein, Daxx has been shown 
to form a complex with USP7 and MDM2. Daxx acts as a bridging factor between 
MDM2 and USP7 that result in MDM2 stabilization by deubiquitylation (Tang et al., 
2006). EBNA1 binds to the TRAF domain of USP7 thereby preventing p53 binding. 
This results in destabilization of p53. Thus, EBNA1 favours cell survival in infected 
cells by lowering p53-mediated apoptosis (Saridakis et al., 2005). 
USP7 is also implicated in regulation of tumor suppressors PML 
(promyelocytic leukemia), PTEN (phosphatase and tensin homologue deleted in 
chromosome 10) and INK4a. USP7 is found to be partially associated with PML 
nuclear bodies (PML-NB), which control several cellular functions including antiviral 
effects, cell cycle and apoptosis. EBNA1 binding to USP7 results in its stabilization 
which induces PML ubiquitylation and degradation (Everett et al., 1997a; Sarkari 
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et al., 2011; Sivachandran et al., 2008). Nuclear exclusion of tumor suppressor 
PTEN has been associated with cancer development. USP7 has been shown to 
induce the nuclear export of PTEN by deubiquitylation (Song et al., 2008). USP7 in 
complex with USP11 was shown to stabilize the mammalian polycomb repressive 
complex (PRC-1) subunits which results in initiation of PRC1-mediated silencing of 
the INK4a tumor suppressor gene (Maertens et al., 2010). USP7 has been shown to 
modulate oxidative stress. In response to oxidative stress, transcription factor FOXO 
(Forkhead box O) gets monoubiquitylated which induces its nuclear localization.
USP7 TRAF CD Ubl Ubl Ubl Ubl Ubl
1 53 208 560 1102
p53
MDM2
EBNA1
FOXOGMPS
MDMX
USP7 DNMT1
UHRF1
Polycomb regulation
DNA methylation
USP11
PRC1
FOXO
Oxidative stress
MDM2
p53
DAXX
p53 regulation
PTEN
PML
PTEN regulation
Histone deubiquitilation
UbUb Ub
UbUb
GMPS
EBNA1
A)
B)
Figure 3; A) Domain organisation of USP7; TRAF (TNF-receptor associated factors) domain, 
CD (catalytic domain) and Ubl (ubiquitin like) domain.
B) Schematic representation of multifaceted roles of USP7 in the regulation of key tumor 
suppressors such as, p53, PTEN, PML and p16INK4a, oxidative stress and epigenetic 
regulation of gene expression.
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USP7 deubiquitylates FOXO and negatively regulate its transcriptional activity 
(van der Horst et al., 2006). USP7 also has a role in epigenetic silencing through the 
modulation of DNA methylation. DNA methyltransferase 1 (DNMT1) is the primary 
enzyme that maintains DNA methylation. USP7 has been shown to stabilize DNMT1 
by deubiquitylation. In colon cancers, overexpression of DNMT1 is correlated with 
expression of USP7 (Du et al., 2010). By stabilizing DNMT1, USP7 indirectly influences 
the increase of DNA methylation at the promoters of genes that results in silencing 
of expression of the downstream genes. For example, hyper-methylation of DNA 
at the CDK2NA locus which encodes two important tumor suppressors INK4a and 
ARF, resulted in the silencing of their expression in several cancers (Magdinier and 
Wolffe, 2001). Therefore, by negatively controlling tumor suppressors PML, PTEN, 
ARF and INK4a, USP7 actively participates in cancer development (Figure 3B).
Tumor suppressor p53/TP53
p53 is a sequence-specific DNA-binding transcription factor that functions in 
a complex signalling network to mediate cellular adaptation to stress (Levine, 
1997). p53 mediates stress response to diverse cellular insults, such as oncogene 
activation, DNA damage, telomere erosion, metabolic stress, DNA replication stress, 
dysfunction of mitotic apparatus, hypoxia, and oxidative stress. Upon stress, p53 
gets stabilized and activates the expression of genes that regulate cell cycle arrest, 
senescence, apoptosis, DNA repair, antioxidant production and metabolism. (Ryan 
et al., 2001; Vousden and Lane, 2007). Schematic representation of the mechanism 
of p53 activation and response is represented in Figure 4. p53 is also implicated 
in the regulation of diverse metabolic pathways including nucleotide biosynthesis 
and coordination of stress responses with changes in cell metabolism (Vousden 
and Prives, 2009). Recent reports suggest that alterations in cell metabolism plays 
a vital role in the cause of diseases such as cancer (Maddocks and Vousden, 2011). 
Early observations on altered energy metabolism in cancer cells were reported by 
Otto Warburg in 1920s, now popularly termed the “Warburg effect” (Warburg, 1956). 
p53 activation upon metabolic stress opposes the ‘Warburg effect’ by inhibiting 
glycolysis and at the same time activating the oxidative phosphorylation pathway. 
Thus, in terms of metabolism, loss of p53 may provide a significant growth advantage 
to the cancer cells (Jones and Thompson, 2009). Therefore, either deletion of the 
p53 gene or downregulation of p53 protein levels or the loss of p53 function due 
to mutations in the DNA binding domain that abolishes its transcription function, 
altogether is the cause of more than 50% of the human cancers (Lane, 1992). 
The tumor suppressive functional outcome is directly correlated to the p53 
protein levels that are regulated by ubiquitylation, which is mainly catalysed by the 
E3 ubiquitin-ligase MDM2 (Oliner et al., 1992). USP7 has been shown to stabilize p53 
by deubiquitylation in overexpression assays (Li et al., 2002). However, knockdown 
of USP7 does not decrease p53 levels as expected but rather than an increase in 
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p53 levels was observed. This is because of USP7’s ability to stabilize MDM2 by 
deubiquitylation (Cummins et al., 2004). In fact, MDM2 was found to be a stronger 
binding partner for USP7 than p53 (Sheng et al., 2006). Thus, p53 stabilization by 
USP7 appears to be a rather complex process that still remains enigmatic. Stability 
of MDM2 is regulated by autoubiquitylation and proteasomal degradation. 
Therefore, under normal condition MDM2 is stabilized by USP7 and this in turn 
negatively regulates p53. Daxx has been shown to stabilize MDM2 by forming a 
complex with USP7. Upon induction of genotoxic stress, MDM2 disassociates 
from Daxx and USP7 resulting in its degradation by autoubiquitylation (Tang et 
al., 2006). Therefore, Daxx and USP7 negatively influence p53 stability through the 
stabilization of MDM2. While USP7 was shown to deubiquitylate p53 in the nucleus, 
recently USP10 has been reported as a deubiquitinase for p53 in the cytoplasm 
(Yuan et al., 2010).
p53
Oncogene activation
DNA damage
Hypoxia
Metobolic stress
Dysfunction of 
mitotic apparatus
DNA replication stress
Nucleotide depletionTelomere erosion
Nitric oxide
Oxidative stress
Cell cylce arrest
Antioxidant
defence
DNA repair
Metabolic
homeastasis
Senescence
Apoptosis
( TIGAR, SCO2, DRAM, GMAT)
(p21                      )
(BAX, PUMA, NOXA)
(PGM, NQO1, GPX1, ALDH4)
WAF1/CIP1
(p53R2, GADD45)
mild stress severe stress
(PML, PAI-1, DEC1)
Figure 4; Mechanisms of p53 activation and response to the diverse cellular insults: p53 
mediates the cellular adaptation to stress by transcriptional regulation of genes involved in 
cell cycle arrest (p21), DNA repair (p53R2, GADD45), antioxidant defence (PGM, NQO1, GPX1, 
ALDH4) and genes that regulates metabolic homeostasis (TIGAR, SCO2, DRAM, GMAT). Upon 
severe damage to the cell, p53 activates cell death pathways such as senescence (PML, PAI-
1 and DEC1) and apoptosis (PUMA, BAX and NOXA), (Qian and Chen, 2010; Vousden and 
Prives, 2009).
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Tripartite motif 21 (TRIM21)
TRIM (Tripartite motif) proteins are the RING finger containing E3 ubiquitin-ligases. 
The presence of a RING, B-box and coiled-coil motif (RBCC) is characteristic of TRIM 
family proteins. There are more than 70 TRIM proteins identified so far in humans 
and mice (Table1). TRIMs are broadly classified into eleven groups based on the 
presence of additional domains. TRIMs are involved in the regulation of broad range 
of biological processes and their alterations are associated with diverse disease 
conditions, such as viral infections, neurological disorders, cancers and autoimmune 
diseases (Hatakeyama, 2011). TRIM21 is also called RO52 or SSA1. It was originally 
identified as an autoantigen commonly found in patients with Sjogren’s syndrome, 
a chronic autoimmune disease characterized by the dryness of eyes and mouth. 
TRIM21 was later characterized as a RING finger protein with intrinsic E3 ubiquitin-
ligase activity (Wada and Kamitani, 2006). The known substrates for TRIM21-
mediated ubiquitylation include IRF3, IRF5, IRF7 and IRF8. TRIM21 is reported to 
be predominantly present in the cytoplasm but upon cellular exposure to different 
reactive oxygen species (ROS) such as hydrogen peroxide (H
2
O
2
), nitric oxide (NO), 
as well as type I interferon (INFa) it translocates to the nucleus. Thus, TRIM21 plays a 
crucial role in the inflammatory responses and is reported to be upregulated at the 
sites of autoimmune inflammation (Oke and Wahren-Herlenius, 2012). 
R B2 CCB1 COS FN3 PRY SPRY
R B2 CCB1
R B2 CCB1 COS ACID
R B2 CCB1 COS FN3
R B2 CCB1 PRY SPRY
R B2 CCB1 NHLFIL
R B2 CCB1 MATH
R B2 CCB1 ARF
R B2 CCB1 FIL
R B2 CCB1 TM
TRIM1, TRIM9, TRIM18, TRIM36, TRIM46, TRIM67 
TRIM54, TRIM55, TRIM63
TRIM42
TRIM4, TRIM5, TRIM6, TRIM7, TRIM10, TRIM11, TRIM15,
TRIM17, TRIM21, TRIM22, TRIM25, TRIM26, TRIM27, 
TRIM34. TRIM35, TRIM38, TRIM39, TRIM41, TRIM43,
TRIM47, TRIM48, TRIM49, TRIM50, TRIM58, TRIM60, TRIM62
TRIM64, TRIM65, TRIM68, TRIM69, TRIM72, TRIM75, TRIML1
TRIM8, TRIM19, TRIM31, TRIM40, TRIM52, TRIM56, TRIM61,
TRIM73, TRIM74
TRIM24, TRIM28, TRIM33
TRIM2, TRIM3, TRIM32, TRIM71
TRIM37
TRIM23
TRIM45
TRIM13, TRIM59
G-XI
G-VIII
G-IX
G-X
G-I
R B2 CCB1 PHD BROMOG-VI
G-VII
G-II
G-III
G-IV
G-V
Subgroup TRIM family MembersDomain structure
Table1: Classification and domain overview of TRIM family protein
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TRIM21 is also implicated in cell cycle regulation through the ubiquitylation 
and degradation of cell cycle inhibitor p27 during S-phase progression (Sabile et al., 
2006). TRIM21 also regulates stability of the transcription factor CCAAT/enhancer-
binding protein alpha (C/EBPa) that functions in cell differentiation. Downregulation 
of C/EBPa by TRIM21was found to be a key mechanism in the development of lung 
cancer (Grandinetti et al., 2011). Elevated levels of TRIM21 antibodies were also 
found in the serum of patients with oesophageal squamous cell carcinoma and 
colon cancer. Presence of serum TRIM21 antibodies correlated with tumor size and 
the disease progression (Kuboshima et al., 2006). Melanoma antigen (MAGE) proteins 
were identified in complex with the TRIM E3 ubiquitin-ligases. MAGE family proteins 
are cancer/testis-antigens that are highly expressed in cancers and play a crucial 
role in the tumorigenesis. MAGE proteins were shown to stimulate the ubiquitin-
ligase activity of TRIM E3 ubiquitin-ligases. For example, MAGE-C2 was shown to 
be the stimulator of TRIM28 E3 ubiquitin-ligase activity towards ubiquitylation and 
degradation of tumor suppressor p53 (Doyle et al., 2010). 
ATP-dependent chromatin remodeling complexes
Chromatin remodelers are multi-subunit enzyme complexes containing an ATPase 
subunit to slide nucleosomes along DNA, to remove/exchange histones, or to alter 
histone-DNA contacts by using energy derived from ATP hydrolysis. Currently, there 
are four major classes of chromatin remodeling complexes SWI/SNF, INO80, ISWI 
and the Mi2 or CHD family. These classes are named after the core ATPase subunit. 
All the four classes of remodelers differ in their subunit composition, specialized for 
particular purpose and biological context. The functional diversity of remodelers is 
determined by the specialized domains present in the ATPase subunit and also by 
the domains of the associated unique subunits (Clapier and Cairns, 2009; Smith and 
Peterson, 2005). The ATPase subunit of SWI/SNF, Swi2 or Brahma or Brg1, contains 
a bromodomain and an AT-hook regions. Bromodomains selectively recognize 
the acetyl-histone tails and the AT-hook domain binds to AT-rich DNA (Mohrmann 
and Verrijzer, 2005). The ISWI, ATPase contains SANT and SLIDE domains. The SANT 
domain structurally related to the cMYB DNA-binding domain, binds to histone tails 
and the SLIDE domain mediates DNA interactions (Langst and Becker, 2001). INO80 
consists of a helicase-SANT domain (HSA) that mediates histone binding (Watanabe 
and Peterson, 2010). The Mi2/CHD4 ATPase consists of tandem chromodomains 
that bind to histone tails, particularly methylated histones and nucleosomal DNA 
(Brehm et al., 2004). Although remodelers are classified into four major groups, 
several sub-complexes were reported based on the combinatorial assembly of 
subunits. Sub-complexes perform common as well as unique functions depending 
on the cell type, developmental stage and chromatin targeting (Clapier and Cairns, 
2009).  Here, we discuss in detail about the NuRD chromatin remodeling complex.
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Composition and functions of the NuRD complex
Nucleosome Remodeling and Deacetylase (NuRD or Mi2) complex contains 
enzymatic subunits such as an ATPase, chromatin-helicase-domain 3 (CHD3, also 
called as Mi2a) and CHD4 (Mi2b or Drosophila Mi2/dMi2) and histone deacetylase 
1 (HDAC1 or RPD3) and HDAC2 (Tong et al., 1998; Wade et al., 1998; Xue et al., 
1998; Zhang et al., 1998). Mi2/CHD4 was originally identified as an autoantigen 
found in the connective tissue disease dermatomyositis (Ge et al., 1995). Mi2 
is a chromatin helicase containing an ATPase domain, chromodomains, PHD 
fingers and a putative DNA binding domain (Woodage et al., 1997). HDACs were 
identified originally as proteins closely related to yeast RPD3, a known regulator 
of gene expression. Biochemical characterization of these proteins revealed that 
they possess histone deacetylase activity (Taunton et al., 1996). Thus, at the time 
of discovery NuRD complex was found to be unique as it couples both chromatin 
helicase and histone deacetylase activities in the same complex. Since histone 
deacetylation is implicated in gene silencing, the NuRD complex is thought to be a 
transcription repressor complex. Recently, lysine specific demethylase 1A (LSD1 or 
KDM1A) was also identified as a subunit of the NuRD complex (Wang et al., 2009). 
LSD1 is a histone H3K4 demethylase implicated in transcriptional repression (Wang 
et al., 2009). Other non-enzymatic subunits include metastasis-associated gene 1 
(MTA1), MTA2 and MTA3, methyl-CpG-binding domain 2 (MBD2 or MBD like-A) and 
MBD3 (MBD like-B) and retinoblastoma-binding protein 4 (RBBP4 or RBAP48 or 
p55/CAF1) and RBBP7 (RBAP46). GATA-like transcription factors, GATAD2A (p66a) 
or GATAD2B (p66b) were also found in complex with NuRD (Brackertz et al., 2002; 
Feng et al., 2002; Wade et al., 1999). GATAD2A, GATAD2B, RBBP4 and RBBP7 were 
shown to interact with histone tails and thought to be the structural components 
of NuRD (Brackertz et al., 2006; Marhold et al., 2004). MTA and MBD subunits are 
implicated in gene regulation by targeting the NuRD complex to different genomic 
loci through association with transcription factors or methylated DNA, respectively 
(Fujita et al., 2004; Hendrich and Bird, 1998). A schematic overview of the subunit 
composition of Drosophila NuRD and human NuRD is given in Figure 5 and the 
domain organization of the subunits is displayed in Table 2.
The formation of alternate and sub-complexes by combinatorial assembly 
of subunits determines the functional specificity of the NuRD. For example, in 
Drosophila, Mi2 and MEP1 form a two-subunit complex called dMec. dMec is shown 
to be functionally different from classical NuRD complex (Kunert et al., 2009). 
Although it has been reported that NuRD subunits are expressed ubiquitously in 
different cell types, some paralogues of NuRD subunits are expressed specifically 
in certain tissue types. For example, CHD5, a brain-specific paralogue of CHD4 is 
found in a NuRD-like complex with similar functions as canonical NuRD (Potts et 
al., 2011; Thompson et al., 2003). Similarly, MTA family members were also found 
in alternate NuRD complexes. For example, MTA3 is a B cell specific paralogue of 
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MTA. MTA3 interacts with transcription factor BCL6 and targets NuRD to different 
genomic loci to regulate B cell differentiation (Fujita et al., 2003). MBD2 and MBD3 
were also shown to form mutually exclusive NuRD complexes with different 
biochemical and functional properties (Le Guezennec et al., 2006). MBD2 has 
been shown to bind methylated DNA through its MBD domain and this function 
of MBD2 is evolutionarily conserved throughout higher eukaryotes. In contrast, 
MBD3 cannot bind to the methylated DNA because of amino acid mutation in its 
MBD domain. Instead, the MBD domain of MBD3 is shown to participate in protein-
protein interactions (Hendrich and Tweedie, 2003; Saito and Ishikawa, 2002). 
Some of the NURD subunits were also found in multiple protein complexes. For 
example, HDAC1 and HDAC2 were found in the Sin3A and CoREST complexes as 
enzymatic subunits (Grozinger and Schreiber, 2002; Yang and Seto, 2008; You et al., 
2001). It remains unclear whether these multiple HDAC complexes are targeted to 
different genomic loci or to the same genomic loci to work synergistically. Some 
NuRD subunits were also reported in complexes other than NuRD. For example, 
RBBP4 and RBBP7 were found in a complex with histone chaperones. They act 
as structural components to provide stability to the complex by protein-protein 
interactions (Loyola and Almouzni, 2004).
PHD PHD CHROMO CHROMO ATPase
CD RB binding
BAH ELM SANT Zn
MBDbd Zn
WD WD WD WD WD WD
Mi2 / CHD3, CHD4,
           CHD5
RPD3 / HDAC1, 
              HDAC2
GR MBD TRD
MBD (A) / MBD2
MBD EMBD (B) / MBD3
MTA1, MTA2, MTA3
p66/68 / GATA2A, 
                 GATA2B
p55 / RBBP4, 
           RBBP7
Subunit Domain structure Description
CHD3, CHD4 and CHD5 core subunit consits of PHD fingers 
for recognition of histone modification. The chromo domains 
display DNA binding activity and ATPase domain carry 
ATP hydrolysis required for chromatin remodeling
MTA contains BAH domain required for protein-protein
interactins, SANT and Zinc finger domain for DNA binding
The function of ELM domain is not known.
GATA transcription factors contains MBD binding domain
and Zinc finger interacts with histones and recognises
specific DNA elements
Histone deacetylases remove acetyl mark from histones,
involved in control of gene expression. Also contains 
RB binding domain at C-terminus.
Histone binding proteins with WD repeats binds to 
histone H4
MBD2 binds to methylated DNA and contains GR repeats
and TRD domain that reqruits HDACs
MBD domain of MBD3 does not bind to binds to methylated 
DNA. MBD3 contains glutamic acid (E) repeats at C-terminus
KDM1A SWIRM Oxidase Oxidase Histone H3 K4 demethylase, contains SWIRM,helix loop helix domain and binds to DNA. Oxidase domain 
mediates demethylation.
Table 2; Domain overview of sub units of the NuRD complex
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p66/68
MTA1 RPD3
p55
MBD(B)
MBD(A)
Mi2
Drosophila NuRD Human NuRD
HDAC1
HDAC2
RBBP4
RBBP7
MBD3
MBD2MTA3
GATAD2B
CHD3
GATAD2A
KD
M
1A
MTA2
MTA1 CHD4
Figure 5; Cartoon representing the subunit composition of Drosophila NuRD and human 
NuRD complex.
Chromatin remodeling and gene regulation by NuRD complex
NuRD is a unique chromatin remodeling complex comprising of different 
chromatin directed enzymatic activities, such as chromatin helicase activity, 
histone deacetylation and histone demethylation. By combining these three 
enzymatic activities NuRD plays a crucial role in the control of gene expression. The 
fundamental property of the chromatin remodeler is to mobilize the nucleosomes 
by utilizing energy derived from ATP hydrolysis. The outcome of remodeling could 
be equal spacing of nucleosomes or disassembly and repositioning of nucleosomes 
(Hota and Bartholomew, 2011). The ATPase activity of Mi2 is stimulated by 
nucleosomes but not by free histones or by free DNA. Both in vitro and in vivo 
studies have demonstrated that Mi2 pulls the nucleosomes towards the center of its 
binding site on the chromatin (Brehm et al., 2000; Moshkin et al., 2012). Nucleosome 
remodeling by Mi2/CHD4 has been implicated in Pol-I mediated transcriptional 
activation of rRNA genes (Xie et al., 2012). However, the precise role of chromatin 
helicase activity of NuRD in Pol-II mediated transcription remains unclear. Histone 
deacetylation by HDACs leads to stabilization of histone-DNA contacts which 
results in compact chromatin and repression of gene expression (Bowen et al., 
2004; Lai and Wade, 2011). LSD1 is a histone H3K4 specific demethylase (Shi et al., 
2004). H3K4 methylation is considered to be hallmark of transcription activation. 
Therefore, H3K4 demethylation by LSD1-NuRD results in transcriptional repression 
(Wang et al., 2009). Thus, NuRD couples the histone deacetylation and histone 
H3K4 demethylation activities for silencing its target genes. Other than having 
enzymatic subunits, MDB2 has been shown to bind methylated DNA to establish 
repressive chromatin state (Zhang et al., 1999). The combination of enzymatic and 
non-enzymatic subunits of NuRD favors the formation of repressive chromatin 
that results in silencing of gene expression (A schematic representation of the 
transcriptional roles of NuRD is given in Figure 6). 
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Non-transcriptional mechanisms
NuRD
Transcriptional mechanisms
Chromatin remodeling
Mi2/CHD4
A)
Transcription ‘ON’
D)
Mi2/CHD4
PARP
DNA damage response and repair
B)
HDAC1/2
Ac
p53
p21
S - phase ‘ON’
Ac
p53 p21
S - phase ‘OFF’
Cell cycle regulation
Ac
B)
HDAC1/2
Histone deacetylation
Ac Transcription ‘OFF’
Ac Ac
A)
Chromatin assembly
p55
/CAFPCN
A
p55/CAF S - phase
PCNA
C)
KD
M
1A
CH3 CH3
CH3 Transcription ‘OFF’CH3
Histone H3K4 demethylation
D)
CH3 CH3 CH3 CH3
MBD2
Transcription ‘OFF’
binding to methylated DNA
C)
Ac
Metastasis and Angiogenesis
HIP1a HIP1a
unstable
Ac
HIP1a
stable
HDAC1/2MTA1
Figure 6; Schematic representation of transcriptional and non-transcriptional roles of NuRD 
complex
Non-transcriptional roles of NuRD complex
The NuRD complex is also implicated in chromatin assembly, cell cycle regulation, 
maintenance of genome stability and aging (Chou et al., 2010; Pegoraro et al., 2009; 
Polo et al., 2010; Smeenk et al., 2010). For example, the p55 (CAF1 or RBBP4) subunit 
assembles chromatin in a replication-dependent manner during the S-phase of cell 
division (Verreault et al., 1996). NuRD is found to be associated with the pericentric 
heterochromatin during S-phase of the cell cycle in rapidly proliferating cells. This 
association is linked to the DNA replication and chromatin assembly. Therefore, 
the p55-NuRD complex is thought to be involved in assembly of chromatin during 
S-phase (Helbling Chadwick et al., 2009). NuRD also has a role in DNA damage 
response and cell cycle control. Poly ADP-ribose polymerase (PARP) binds to CHD 
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to recruit NuRD to the sites of DNA damage for efficient repair of the DNA double 
strand breaks (Polo et al., 2010). HDAC1, a subunit of NuRD, was shown to deacetylate 
p53 which is essential for the transition of G1/S phase of the cell cycle (Polo et al., 
2010). Knockdown of CHD4 and MTA2 leads to accumulation DNA double strand 
breaks (DSB) and the cells become sensitive to ionizing radiation. It has been shown 
that CHD4 mediates DSB repair and check point activation in response to ionizing 
radiation (Smeenk et al., 2010). Therefore, NuRD plays a crucial role in DNA damage 
response and repair. Loss of several of the NuRD subunits is found to be associated 
with the premature aging. Silencing of the individual NuRD subunits resulted in 
chromatin defects associated with aging through the accumulation of DNA DSBs. 
Therefore, NuRD is considered to be essential for the maintenance of chromatin 
structure to prevent the DNA damage and premature aging (Pegoraro et al., 2009). 
The HDAC1 subunit of NuRD has been shown to stabilize HIF-1a (hypoxia inducible 
factor 1 alpha) by deacetylation. Stabilization of HIF-1a is found to be the key factor 
in initiation of tumor angiogenesis (Yoo et al., 2006). Thus, NuRD plays a crucial role 
in regulation of chromatin assembly, genome stability, aging and angiogenesis 
(see Figure 6 for an overview of non-transcriptional roles of the NuRD complex). 
Role of NuRD complex in development and disease
Several NuRD subunits play a significant role in normal development of the 
organism. For example, in C. elegans, MEP1 in association with LET-418 (orthologue 
of Mi2) and HAD-1 (orthologue of HDAC1) are essential for the maintenance of germ 
line-soma distinctions (Unhavaithaya et al., 2002). NuRD also plays an important 
role in the differentiation of haematopoietic stem cells into lymphoid and myeloid 
cells (Yoshida et al., 2008). NuRD is also required for development of T-lymphocytes 
(Williams et al., 2004). MBD3-NuRD is found to be essential for the maintenance of 
pluripotency and initiation of differentiation programme in embryonic stem cells 
(Kaji et al., 2006; Zhu et al., 2009). Knockout and transgenic mouse models of NuRD 
subunits reveal that it has a role in normal developmental processes. For example, 
the Mbd3 knockout mouse is embryonic lethal, in contrast to Mbd2 knockout mice 
that are viable with mild defects (Hendrich and Tweedie, 2003). NuRD also plays 
a crucial role in peripheral nerve myelination by Schwann cells. Mice with CHD4 
knockout in Schwann cells showed delayed hypomyelination and persistence of 
promyelinating Schwann cells (Hung et al., 2012). Thus NuRD plays an important 
role at different developmental stages of an organism. 
 Mi2 was originally identified as an autoantigen found in patients with 
dermatomyositis (Ge et al., 1995). About 15-25% of patients with dermatomyositis 
eventually develop malignancies (Callen and Wortmann, 2006). However, the link 
between presence of Mi2 autoantibodies and development of cancer remains 
unclear. MTA family members have been implicated in the development of several 
cancers, including breast cancer (Kumar et al., 2003; Toh and Nicolson, 2009; Zhang 
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et al., 2006). Overexpression of MTA1 is observed in tumors derived from several 
tissue origins in humans, including breast, colon, gastric, endometrial, esophageal, 
pancreatic, ovarian, prostate, liver, B-lymphocytes and non-cell-lung cancer 
(Nicolson et al., 2003). MTA1-NuRD is a potent repressor of oestrogen receptor (ER)-
dependent transcription resulting in disruption of oestrodial responsiveness, thus 
contributing to progression to more invasive forms of breast cancer (Mazumdar et al., 
2001). More specifically, MTA1-NuRD represses the expression of tumor-suppressor 
BRCA1 which results in chromosomal instability and development of malignancy 
(Molli et al., 2008). In contrast, MTA3-NuRD acts as a tumor suppressor in ER-negative 
breast cancers. MTA3 is induced in an oestrogen-dependent manner and represses 
the expression of transcriptional repressor Snail, a key promoter of epithelial-to-
mesenchymal transition (EMT).  Therefore, absence of either ER or MTA3 results in 
aberrant expression of Snail which results in repression of the cell adhesion protein 
E-cadherin. Loss of E-cadherin expression is the cause for EMT and invasive growth in 
breast tumors (Fujita et al., 2003). Therefore, the balance between MTA1-NuRD and 
MTA3-NuRD complexes might be a determining factor in breast cancer development. 
 Aberrant DNA methylation at gene promoters is the most commonly 
observed phenomenon in human cancers. Promoter hyper-methylation leads 
to repression of downstream target genes, such as key tumor suppressor genes 
including Retinoblastoma protein (RB), INK4a and BRCA1 (Costello et al., 2000; 
McCabe et al., 2009). The mechanism of gene silencing by promoter hyper-
methylation involves the recruitment of MBD proteins and their associated 
repressor complexes leading to formation of a repressive chromatin state (Zhang 
et al., 1999). MBD2 was found at the hyper-methylated promoter region of the 
CDK2NA locus which encodes the tumor suppressors ARF and INK4a. Expression 
of these proteins is repressed in colon cancers (Magdinier and Wolffe, 2001). 
Consistent with this observation MBD2 has been shown to recruit the co-repressor 
complexes to the promoters of hyper-methylated DNA for efficient initiation of 
tumorigenesis in the mouse intestine. Systemic deletion of Mbd2 results in the 
suppression of tumor formation in these colon cancer mouse models (Sansom et al., 
2003). Some of the NuRD subunits are found deleted in certain type of cancers. For 
example, CHD5, a brain specific paralouge of Mi2/CHD4 is present at chromosome 
1p36. Deletion of 1p36 locus is the most frequent genetic lesion in human cancers 
of epithelial, neural and hematopoietic origin. In mouse models, CHD5 suppresses 
the tumor growth by activating the ARF/p53 pathway in mouse models (Bagchi 
et al., 2007). NuRD as a complex has the potential to either induce or suppress the 
development of tumors by forming alternate complexes. Therefore, understanding 
the composition and functional diversity of the NuRD complex might shed light 
towards identifying therapeutic targets for cancer.
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Summary
Functional outcomes of tumor suppression by p53 are tightly coupled to its 
nuclear levels, which are controlled predominantly through ubiquitylation by 
MDM2 and deubiquitylation by ubiquitin specific protease 7 (USP7). Here, we show 
that biosynthetic enzyme guanosine 5’-monophosphate synthetase (GMPS) is 
required for stress-induced stabilization of p53. GMPS predominantly resides in the 
cytoplasm, but following genotoxic- or replicative stress GMPS accumulates in the 
nucleus. Here, it drives the formation of a GMPS-USP7-p53 complex, in which p53 is 
deubiquitylated and stabilized. Stabilization of endogenous p53 by USP7 requires 
GMPS. The cytoplasmic E3 ubiquitin-ligase TRIM21 controls GMPS subcellular 
localization, and depletion of TRIM21 leads to GMPS-dependent induction of 
p53. Normally, TRIM21 binds and ubiquitylates GMPS to retain it in the cytoplasm, 
but stress triggers the release of GMPS and its nuclear accumulation. Our results 
delineate a TRIM21-GMPS-USP7 molecular cascade that mediates p53 stabilization 
in response to cellular stress.
Introduction
p53 is a sequence-specific transcription factor that is a central regulator of cellular 
homeostasis and tumor suppression (Lane and Levine, 2010). p53 can direct a 
variety of responses ranging from cell cycle arrest, cellular senescence, cell death, 
cell survival, DNA repair and metabolic adaptation. Reflecting this myriad of 
cellular outcomes, p53 itself is regulated at multiple levels, involving a plethora 
of different post-transcriptional modifications (Bieging and Attardi, 2012; Brown 
et al., 2009; Jayaraman and Prives, 1999; Maddocks and Vousden, 2011; Sullivan 
et al., 2012; Vogelstein et al., 2000). The levels of p53 expression need to be tightly 
controlled as loss of p53 predisposes to cancer, but over-expression of p53 can 
promote accelerated aging or even lethality. Normally, p53 protein levels are 
kept low as a consequence of its high turnover due to continuous ubiquitylation 
followed by proteasomal degradation. Upon cellular stress there is a dramatic drop 
in p53 ubiquitylation, leading to its accumulation (reviewed in Brooks and Gu, 
2011; Coutts et al., 2009; Hock and Vousden, 2010).
 Briefly, the RING domain protein MDM2 is the major E3 ubiquitin-ligase 
for p53 (Kubbutat et al., 1997; Hock and Vousden, 2010). MDM2 mediates lysine 
48-linked polyubiquitylation of p53, targeting it for proteasomal degradation. 
In addition, monoubiquitylation by MDM2 stimulates its nuclear export to the 
cytoplasm. Studies in mice have established that MDM2 and p53 functions are 
intricately linked, and that the E3 ligase activity of MDM2 is crucial for in vivo control 
of p53 (Itahana et al., 2007; Montes de Oca Luna et al., 1995; Ringshausen et al., 2006). 
Stabilization of p53 following cellular stress involves both a loss of ubiquitylation 
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by MDM2 and its deubiquitylation. USP7 (a.k.a. HAUSP) has emerged as the major 
deubiquitylating enzyme (DUB) controlling the MDM2-p53 pathway. Originally, 
cotransfection over-expression studies showed that USP7 can bind and stabilize 
p53 by deubiquitylation (Li et al., 2002). Paradoxically, knockout of the USP7 gene 
or RNAi-mediated depletion of endogenous USP7 also resulted in p53 stabilization 
(Cummins et al., 2004; Li et al., 2004). In the absence of deubiquitylation by USP7, 
MDM2 becomes unstable and is degraded, leading to reduced p53 ubiquitylation. 
Thus, USP7 plays a central, but dualistic, role in the regulation of p53. Complicating 
matters further, USP7 regulates other proteins that cross-talk with p53, and its activity 
is regulated by a variety of factors (Epping et al., 2011; Frappier and Verrijzer, 2011; 
Khoronenkova et al., 2012; Meulmeester et al., 2005; Saridakis et al., 2005; Sarkari et 
al., 2009; Song et al., 2008; van der Knaap et al., 2010; van der Knaap et al., 2005).
 One intriguing partner protein that stimulates USP7 activity is the 
nucleotide biosynthetic enzyme GMPS (van der Knaap et al., 2005). GMPS 
mediates the final step of the de novo synthesis of guanine nucleotides, converting 
xanthosine 5’-monophosphate (XMP) into GMP, a building block of DNA and RNA. 
Purification of Drosophila USP7 identified GMPS as its major associated protein 
(van der Knaap et al., 2005). Biochemical and genetic evidence established that 
GMPS strongly stimulates histone H2B deubiquitylation by USP7 in Drosophila 
and human cells (Sarkari et al., 2009; van der Knaap et al., 2005; van der Knaap 
et al., 2010). GMPS-USP7 can be targeted to specific genomic loci to direct gene 
expression. For example, GMPS-USP7 binds Polycomb response elements and 
enhances Polycomb-directed silencing of homeotic genes in vivo (van der Knaap et 
al., 2005). In addition, GMPS-USP7 mediates H2B deubiquitylation and transcription 
repression at ecdysteroid regulated genes (van der Knaap et al., 2010). GMPS 
stimulates USP7 activity independent of its own catalytic activity (van der Knaap et 
al., 2010; van der Knaap et al., 2005). GMPS activates USP7 allosterically by inducing 
a conformational change (Faesen et al., 2011). In summary, GMPS does double duty 
as a biosynthetic enzyme and as a USP7-associated chromatin regulator.
 To maintain homeostasis, cells have to coordinate their level of nucleotide 
synthesis and proliferation (Tong et al., 2009). GMPS’s close functional link with 
USP7 made us wonder if it may also be involved in p53 regulation. Suggestively, 
we found previously that Drosophila GMPS in vitro can stimulate deubiquitylation 
of p53 by USP7 (van der Knaap et al., 2005). However, the physiological relevance of 
this observation remains unclear. Here, we show that GMPS is part of a critical switch 
that controls p53 induction. USP7-mediated deubiquitylation- and stabilization of 
p53 is strictly dependent on GMPS, which is regulated by the E3 ubiquitin-ligase 
TRIM21. Thus, GMPS, a biosynthetic enzyme associated with cell proliferation, plays 
a crucial role in regulation of the p53 tumor suppressor.
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Results
GMPS binds USP7 and p53
To identify GMPS-associated factors in human cells, we immunopurified endogenous 
GMPS from whole cell extract (WCE) prepared from U2OS cells (Figure 1A). In 
addition, we expressed a flag-tagged version of GMPS in HEK-293T cells, followed 
by protein isolation from WCE with anti-flag antibodies (Figure 1B). Purified proteins 
were resolved by SDS polyacrylamide electrophoresis (SDS-PAGE) and visualized 
by coomassie staining. Protein identities were determined by massspectrometric 
analysis, which uncovered the association of both endogenous GMPS and flag-
GMPS with USP7 and p53. In addition, we identified nucleotide biosynthetic 
enzymes inosine monophosphate 
dehydrogenase 2 (IMPDH2) and CAD, 
the DUB USP11, the MRN complex that 
is involved in DNA repair, and TRIM21, a 
RING domain protein that belongs to the 
tripartite (TRIM) family. A full overview 
of GMPS-associated proteins is provided 
in Table S1.
Figure 1; GMPS interacts with USP7 
and p53 (A) GMPS-associated proteins 
immunopurified from U2OS whole cell 
extracts (WCE). Cell extracts were incubated 
with Protein A Sepharose beads coated 
with either control anti-GST (mock) or 
affinity purified anti-GMPS antibodies. 
Input, unbound material and IPed proteins 
were resolved by SDS-PAGE and visualized 
by coomassie staining. GMPS-associated 
proteins were identified by nanoflow 
LC-MS/MS mass spectrometry. A full list 
of GMPS-bound proteins is provided in 
Table S1. * indicates background proteins 
and immunoglobins. (B) IPs using anti-
flag antibodies were performed using 
WCEs prepared from 293T cells transiently 
transfected with a vector expressing flag-
GMPS. Analysis as described above. (C-E) 
Genotoxic stress triggers the formation of a 
GMPS-USP7-p53 complex. CoIPs of GMPS (C), 
p53 (D) or USP7 (E) from WCEs prepared from 
U2OS cells that were either mock-treated or 
incubated with 10 mM etoposide (+ETO). 
Mock indicates IP with anti-GST antibodies. 
Associated proteins were resolved by SDS-
PAGE and analyzed by immunobloting with 
antibodies against the proteins indicated.
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 Next, we investigated the effect of genotoxic stress on the interactions 
between GMPS, USP7 and p53. We immunoprecipitated (IPed) these proteins 
from WCEs from U2OS cells that were either mock treated (-) or incubated with 
the DNA-damaging drug etoposide (+ETO). Protein immunoblotting revealed a 
dramatic change in the pattern of protein-protein interactions after addition of 
etoposide (Figure 1C-E). In the absence of ETO, p53 is predominantly associated 
with MDM2, which in turn is bound by USP7. GMPS binds USP7, but does not 
associate substantially with p53. Long exposure (LE) of the blots revealed weak 
binding of GMPS to p53. We could not detect any interaction between GMPS and 
MDM2, either by mass spectrometry or by immunoblotting analysis. Upon addition 
of etoposide, p53 dissociated from MDM2 and instead bound GMPS and USP7. Like 
p53, USP7 no longer bound MDM2. Thus, genotoxic stress induces the transfer of 
p53 from an ubiquitylating enzyme, MDM2, to a complex comprising GMPS and 
the DUB USP7.
GMPS is required for p53 stabilization
To test their role in the regulation of p53 protein levels, we used shRNAs to deplete 
cellular USP7 or GMPS. We monitored endogenous p53 by immunoflurescence 
using highly specific antibodies (Figure 2A and Figure S1A-F). In non-stressed cells, 
loss of USP7 caused an increase in p53 levels. This is consistent with the notion 
that the main effect of USP7 in these cells is to bind and stabilize MDM2, thereby 
promoting p53 degradation (Cummins et al., 2004; Li et al., 2004). In contrast, 
knockdown of GMPS gave a modest reduction in the level of p53. As expected, 
addition of etoposide caused a strong increase in p53 levels. The induction of p53 
was completely reversed by knockdown of either GMPS or USP7.  Moreover, a 
substantial portion of the remaining p53 in these cells appears to be cytoplasmic. 
These observations were confirmed by protein immunoblotting analysis of cell 
extracts (Figure 2B). Confirming results of others (Li et al., 2002; Maertens et al., 
2010), knockdown of USP11, which also binds GMPS, did not affect p53 levels 
(data not shown). We note that the high level of mutant p53 protein in MDA-231 
cells was not affected by either GMPS or USP7 depletion (Figure S1G-H). Thus, the 
inherent stability of mutant p53 does not appear to depend on GMPS and USP7. We 
conclude that GMPS is required for the induction of wild type p53 upon genotoxic 
stress. USP7 plays a dualistic role: in unstressed cells it is a negative regulator of 
p53, whereas after genotoxic stress USP7 stabilizes p53. 
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Figure 2; GMPS and USP7 are required for p53 induction after genotoxic stress
(A) Indirect immunofluorescence of U2OS cells, cultured in either the absence (-) or presence 
of 10 mM etoposide (+ETO), after knockdown (KD) of GMPS or USP7. Cells were fixed and 
stained with antibodies directed against p53 (red). Nuclei were visualized by DAPI staining 
of DNA (blue). Images were capture by using fluorescent microscope. (B) Immunobloting 
analysis of WCEs of cells treated as described above, using the indicated antibodies. Tubulin 
serves as a loading control. (C) U2OS cells were transfected with vectors expressing flag-
GMPS, flag-GMPSC114A or HA-tagged USP7 (HA-USP7) in the indicated combinations. 
Endogenous p53 and the transfected proteins were detected by immunoblotting with the 
indicated antibodies. (D) GMPS stimulates deubiquitylation of p53 by USP7. H1299 cells 
were transiently transfected with vectors expressing p53, MDM2 and His
6
-ub in combination 
with HA-USP7 or flag-GMPS in the indicated combinations. After 48 hours, cells were 
treated with the proteasome inhibitors MG132 (50 mM) and Lactacystine (5mM) for 4 hours. 
After preparation of WCEs, proteins were detected by immunoblotting with the indicated 
antibodies. (E) Depletion of GMPS or USP7 affects p53 target gene expression. Following 
lentiviral shRNA-mediated knockdown of GMPS, USP7 or p53 and etoposide treatment, 
as described above, total RNA was isolated and gene expression determined by RT-qPCR. 
GAPDH mRNA levels were used for normalization. Changes in expression are represented as 
fold change relative to mock-treated cells. p21 and BAX are activated by p53, ARP is a p53-
independent control gene. Note that p53 mRNA levels are not affected by GMPS or USP7 
depletion. Mean and standard deviations were derived from three independent biological 
replicates. (F) Analysis of CDC6 and MCM6 expression, genes that are repressed by p53. 
 These results can be explained by our protein-protein interaction analysis 
that showed that genotoxic stress induces the transfer of p53 from MDM2 to GMPS-
USP7 (Figure 1). When bound by GMPS-USP7, p53 can be deubiquitylated and 
stabilized (Figure 2C).  The enzymatic activity of GMPS is not required, because the 
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catalytically impaired mutant GMPSC114A also mediated p53 stabilization by USP7. 
This result is reminiscent of our observation that histone H2B deubiquitylation by 
USP7 required GMPS but not its enzymatic activity (van der Knaap et al., 2010; van 
der Knaap et al., 2005), and supports an allosteric mechanism of USP7 activation 
by GMPS (Faesen et al., 2011). In agreement with earlier in vitro results using 
Drosophila GMPS (van der Knaap et al., 2005), co-transfection experiments showed 
that human GMPS stimulates p53 deubiquitylation by USP7 (Figure 2D).
 p53 is a transcription factor that elicits its cellular response by controlling 
gene expression. Therefore, we determined the effect of GMPS- or USP7 depletion 
on the expression of a number of p53 target genes involved in cell cycle control or 
apoptosis. Reverse transcription quantitative PCR (RT-qPCR) revealed that knockdown 
of GMPS or USP7 caused a reduced induction of p21 and BAX after addition of 
etoposide (Figure 2E). Whereas loss of GMPS did not significantly affected p53 target 
gene expression in unstressed cells, knockdown of USP7 caused increased expression 
of p21 and BAX. Thus, the effects on transcription are consistent with the observed 
changes in p53 levels. Examination of two genes that are repressed by p53, CDC6 
and MCM6, yielded a similar result. Knockdown of USP7 or GMPS caused a dramatic 
loss of p53-dependent transcriptional repression. In the absence of etoposide, loss 
of USP7 caused a loss of CDC6 and MCM6 expression (Figure 2F). The expression of a 
p53-independent control gene, ARP, remained unaffected by knockdown of GMPS, 
USP7 or p53. Importantly, neither GMPS- nor USP7 depletion affected p53 mRNA 
levels, confirming that they control p53 post- translationally (Figure 2E). We conclude 
that changes in the expression 
of these p53 target genes 
reflect the effects of GMPS and 
USP7 on p53 protein levels.
Figure 3; Genotoxic stress 
induces nuclear accumulation 
of GMPS
A) Indirect immunofluorescence 
of U2OS cells that were either 
untreated (-), treated with 10 mM 
etoposide (+ETO) for 24 hours, 
or with 50 nM Leptomycin B 
(LMB) for 5 hours. Cells were 
stained with antibodies against 
GMPS (green), and nuclei were 
visualized by DAPI staining of 
DNA (blue). (B) Costaining of 
GMPS (green) and USP7 (red). (C) 
Costaining of GMPS (green) and 
p53 (red). Images were capture by 
using fluorescent microscope.
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Figure 4; GMPS is required for p53 induction in response to nucleotide depletion
(A) Blockage of GMP synthesis by Mycophenolic acid (MPA) leads to the formation of gH2Ax 
foci. Indirect immunofluorescence of U2OS cells were either untreated (-), treated with 5 
mg/ml MPA, 4 mM hydroxy urea (HU) or 10 mM etoposide (+ETO). Cells were stained with 
antibodies against gH2Ax (red), and nuclei were visualized by DAPI staining of DNA (blue). 
Images were capture by using fluorescent microscope. (B) MPA induces accumulation of 
nuclear GMPS. Cells cultured in the absence (-) or presence of 5 mg/ml MPA were stained with 
antibodies against GMPS (green). Images were capture by using fluorescent microscope. (C) 
Replicative stress drives formation of a GMPS-USP7-p53 complex. CoIPs of GMPS from WCEs 
prepared from cells that were cultured in the absence (-) or presence of 5 mg/ml MPA. (D) 
GMPS and USP7 are required for p53 induction by MPA. Indirect immunofluorescence of p53 
(red) in U2OS cells cultured in the presence of 5 mg/ml MPA, following knockdown (KD) of 
GMPS or USP7. Images were capture by using fluorescent microscope.
Genotoxic stress induces the accumulation of nuclear GMPS
We recently established that cytoplasmic-nuclear partitioning is part of the 
mechanism by which nucleotide biosynthetic enzyme IMPDH regulates 
transcription of its target genes (Kozhevnikova et al., 2012). This observation 
prompted us to investigate the subcellular localization of GMPS in the absence 
or presence of etoposide. Immunofluorescence with antibodies directed against 
GMPS (green), in parallel with DAPI staining of DNA (blue), showed that the 
majority of GMPS is normally cytoplasmic (Figure 3A). In the presence of etoposide, 
however, there is a strong increase in the amount of nuclear GMPS. Addition of the 
nuclear export inhibitor Leptomycin B (LMB) to unstressed cells caused a transfer of 
GMPS from the cytoplasm to the nucleus. This result suggests that GMPS shuttles in 
and out of the nucleus, but that active export normally outcompetes import. Upon 
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genotoxic stress, this balance shifts, resulting in the accumulation of GMPS in the 
nucleus. Here, GMPS can bind USP7 (red, Figure 3B) and p53 (red, Figure 3C), which 
are both nuclear proteins. These results suggest that induction of p53 by genotoxic 
stress may be controlled by the subcellular localization of GMPS.
GMPS mediates the p53 response to replicative stress
A recent study suggested that nucleotide deficiency promotes genomic instability 
in early stages of cancer development due to DNA replication stress (Bester et al., 
2011). An attractive idea is that GMPS not only catalyzes a key step in guanine 
nucleotide synthesis, but in case of deficiencies in this process, also mediates a p53 
response. To test this hypothesis, we treated cells with Mycophenolic acid (MPA), an 
inhibitor of IMPDH. IMPDH is the enzyme directly upstream of GMPS that catalyzes 
the oxidation of IMP, generating XMP, the substrate of GMPS. The depletion of 
guanine nucleotides caused by MPA leads to replicative stress, as indicated by the 
formation of gH2Ax foci (Figure 4A). This effect was similar to the well-established 
response to the inhibition of ribonucleotide reductase by hydroxy urea (HU), which 
also causes replicative stress or the induction of DNA breaks by etoposide.
 Next, we tested if GMPS subcellular localization changed in response to 
depletion of its substrate XMP. Immunoflurescence showed that the addition of 
MPA caused a dramatic increase in the amount of nuclear GMPS (Figure 4B). Co-IPs 
confirmed the association of GMPS with p53 and USP7 following the addition of 
MPA (Figure 4C). Knockdown of GMPS or USP7 caused a strong reduction in p53 
levels (Figure 4D).  Moreover, in the absence of GMPS or USP7, a substantial portion 
of the remaining p53 is cytoplasmic. These results suggest that GMPS not only 
produces GMP, but also mediates the induction of p53 in response to imbalances 
in the GMP synthesis pathway. In other words, GMPS is not only a biosynthetic 
enzyme allowing cell proliferation, but also part of a checkpoint that prevents 
genomic instability as a result of nucleotide deficiency.
TRIM21 retains GMPS in the cytoplasm, preventing p53 induction 
Our results thus far suggest that the accumulation of nuclear GMPS promotes 
p53 stabilization. However, the molecular mechanism by which the bulk of GMPS 
is retained in the cytoplasm of unstressed cells is unclear. Therefore, we set out 
to identify factors that might control the subcellular localization of GMPS. Our 
analysis of GMPS-associated proteins identified TRIM21 (Table S1), an autoantigen 
associated with Sjögren’s syndrome and systemic lupus erythematosus (Yoshimi et 
al., 2012). TRIM21 is a RING-finger E3 ubiquitin-ligase that function in innate and 
acquired immunity. We IPed TRIM21 from either unstressed cells, or cells treated 
with etoposide or MPA. Immunoblotting revealed that in unstressed cells TRIM21 
binds GMPS, but not USP7 or p53 (Figure 5A). Cellular stress, however, caused 
TRIM21 to dissociate from GMPS. We also note that TRIM21 is a cytoplasmic protein 
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(Figure 5B). Thus, TRIM21 may retain GMPS in the cytoplasm of unstressed cells.
 To test its effect on the subcellular localization of GMPS, we used shRNAs 
to deplete endogenous TRIM21.  In the absence of stress, knockdown of TRIM21 
caused translocation of GMPS from the cytoplasm to the nucleus, and strong p53 
induction (Figure 5B). p53 induction upon loss of TRIM21 is strictly dependent 
on GMPS, because the effect is reversed after concomitant knockdown of 
TRIM21 and GMPS. These observations were confirmed by quantification of p53 
immunofluorescence (Figure 5C). Depletion of USP7 or p53 did not affect GMPS 
subcellular localization (Figure S2). We note that knockdown of TRIM21 does not 
induce a DNA damage response, as indicated by the absence of gH2Ax foci (Figure 
5D). Collectively, these results suggest that TRIM21 regulates p53 negatively by 
binding and retaining GMPS in the cytoplasm. In other words, the cytoplasmic-
nuclear partitioning of GMPS by TRIM21 appears to be a switch controlling p53 
levels.
Figure 5; TRIM21 counteracts p53 
stabilization through cytoplasmic 
retention of GMPS
(A) TRIM21 binds GMPS, but dissociates 
upon genotoxic- or replicative stress. 
CoIPs of TRIM21 from WCEs prepared 
from cells that were cultured in the 
absence (-) or presence of 10 mM 
etoposide or 5mg/ml MPA. 
(B) Depletion of TRIM21 suffices for, 
GMPS-dependent, induction of p53. 
Indirect immunofluorescence analysis 
of U2OS cells after KD either TRIM21 or 
GMPS or both TRIM21 and GMPS. Cells 
were fixed and stained with antibodies 
directed against p53 (red), GMPS (green) 
or TRIM21 (turquoise). Images were 
capture by using confocal microscope.
(C) Quantification of p53 
immunofluorescence using fiji-win32 
software, plotted as fold change 
relative to mock-treated cells. Mean and 
standard deviations were derived from 
three independent biological replicates. 
In each case 20 nuclei were used for 
quantification. 
(D) KD of TRIM21 does not induce a DNA 
damage response. Indirect immuno-
fluorescence of U2OS cells after KD of 
TRIM21 or after addition of 10 mM etopo-
side. Cells were stained with antibodies 
against gH2Ax (green). Images were cap-
ture by using confocal microscope.
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Ubiquitylation by TRIM21 controls GMPS subcellular localization
Because TRIM21 is a RING domain E3 ubiquitin-ligase, we decided to investigate 
the potential role of ubiquitylation in controlling GMPS localization. First, we co-
expressed flag-GMPS, TRIM21 and His
6
-tagged ubiquitin (ub) in cells, followed by 
the preparation of nuclear and cytoplasmic fractions. Western immunoblotting 
revealed the ubiquitylation of cytoplasmic, but not nuclear GMPS (Figure 6A). Like 
PTEN (Trotman et al., 2007), efficient ubiquitylation of GMPS required overexpression 
of ubiquitin, and was enhanced by additional TRIM21 (Supplementary Figure 3A). 
We note that, by itself, ectopically over-expressed flag-GMPS mainly localizes in 
the nucleus (Supplementary Figure 3B). Only in the presence of extra TRIM21 and 
ubiquitin does recombinant GMPS, like its endogenous counterpart, localize in 
the cytoplasm (Supplementary Figure 3B). Knockdown of endogenous TRIM21 led 
to a loss of GMPS ubiquitylation, showing it is the responsible ubiquitin-ligase 
(Figure 6B). We note that the migration of ubiquitylated GMPS suggests it is mainly 
monoubiquitylated by TRIM21. 
 To identify the ubiquitylated residues in GMPS we affinity purified 
flag-GMPS, followed by SDS-PAGE and coomassie staining (Figure 6C). Mass 
spectrometric analysis revealed the di-glycine hallmark of ubiquitylation on lysine 
(K) residues K182, K389 and K607 (Figure 6D). To test whether ubiquitylation of 
these lysines is important for the subcellular localization of GMPS we mutated 
them to arginine (R) residues, which cannot be ubiquitylated. Transfection studies 
revealed that in the presence of extra TRIM21 and ubiquitin wild type GMPS was 
mainly cytoplasmic. However, the GMPS K-to-R mutants were nuclear (Figure 6E). 
We conclude that ubiquitylation of these residues by TRIM21 is required for the 
cytoplasmic targeting of GMPS. 
 We wondered if USP7 could counteract TRIM21 and deubiquitylate GMPS, 
thereby shifting the balance towards nuclear retention. Indeed, concomitant over-
expression of USP7, TRIM21 and GMPS led to a nuclear localization of GMPS (Figure 
6F). This was dependent on deubiquitylation by USP7, because the catalytically 
inactive mutant USP7C223S could change the cytoplasmic localization of GMPS. 
Reflecting their effect on the subcellular localization of GMPS, wild type USP7, 
but not USP7C223S, deubiquitylated GMPS in cells (Figure 6G). We conclude that (de)
ubiquitylation is an essential part of the mechanism that controls the subcellular 
localization of GMPS.
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Figure 6; Ubiquitylation by TRIM21 determines the subcellular localization of GMPS
(A) Cytoplasmic, but not nuclear, GMPS is ubiquitylated. Nuclear and cytoplasmic fractions 
were prepared from HEK-293T cells that were transfected with vectors expressing flag-
GMPS, His
6
-ub and HA-TRIM21. Cell fractions were analyzed by immunoblotting with the 
indicated antibodies. See also Figure S3A. (B) TRIM21 is required for GMPS ubiquitylation. 
Immunoblotting analysis of WCEs of HEK-293T, following KD of endogenous TRIM21 cells 
transfected with vectors expressing flag-GMPS and His
6
-ub. (C) flag-GMPS IPed from HEK-
293T cells transfected with vectors expressing flag-GMPS, His
6
-ub and HA-TRIM21, using 
anti-flag M2 agarose beads. Bound proteins were eluted with flag peptides, resolved by SDS-
PAGE and visualized by coomassie staining. Bands corresponding to GMPS were excised 
and analyzed by mass spectrometry. (D) Ubiquitylated lysine residues of GMPS, K182, K389 
and K607, identified by mass spectrometry. The glutamine amidotransferase (GATase) and 
ATP pyrophosphatase (ATP-PPase) catalytic domains of GMPS, and its C-terminal domain 
(CTD), are indicated. The table depicts the peptides identified with the target K in red and 
the ration between modified and unmodified peptides. (E) Mutation of ubiquitylated 
lysines to arginines (K to R) causes the transfer of GMPS from the cytoplasm to the nucleus. 
Indirect immunofluorescence of HEK-293T cells transfected with plasmid vectors expressing 
HA-TRIM21, His
6
-Ub and either wild type flag-GMPS or GMPS-K182R, -K389R or K607R 
mutants. flag-GMPS (green) was detected with anti-flag antibodies. Images were capture 
by using confocal microscope. (F) USP7 promotes nuclear accumulation of GMPS. Indirect 
immunofluorescence of HEK-293T cells transfected with plasmid vectors expressing flag-
GMPS, HA-TRIM21, His
6
-ub, no additional factors (-), USP7 or the catalytically inactive 
USP7C223S mutant. Flag-GMPS (green) was detected with anti-flag antibodies. Images were 
capture by using confocal microscope. (G) USP7 deubiquitylates GMPS. Immunoblotting 
analysis of GMPS in WCEs prepared from cells treated as described above.
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Figure 7; A TRIM21-GMPS-USP7 cascade controls p53 stability
Model summarizing our results. GMPS is essential for cell proliferation as it converts XMP 
into GMP, a precursor of DNA and RNA. Under homeostatic conditions TRIM21 binds and 
ubiquitylates GMPS to keep it predominantly cytoplasmic. In the nucleus, USP7 binds 
and stabilizes MDM2. MDM2 ubiquitylates p53, thereby marking it for degradation by the 
proteasome. Genotoxic- or replicative stress triggers the release of GMPS from TRIM21 
and its accumulation in the nucleus, where it is deubiquitylated by USP7.  Nuclear GMPS 
drives the transfer of p53 from MDM2 to a GMPS-USP7-p53 complex, resulting in p53 
deubiquitylation by USP7. Our results suggest that nuclear-cytoplasmic trafficking of GMPS, 
controlled through ubiquitylation by TRIM21, is a key switch of p53 stabilization by USP7. 
See main text for details.
Discussion
In this study, we established that the nucleotide biosynthetic enzyme GMPS is a 
crucial relay of p53 induction after DNA damage or nucleotide depletion (Figure 
7). Under homeostatic conditions, TRIM21 binds and ubiquitylates GMPS to keep 
it predominantly excluded from the nucleus. In the nucleus, USP7 deubiquitylates 
and stabilizes MDM2, thereby promoting p53 ubiquitylation and degradation. 
Genotoxic - or replicative stress triggers the release of GMPS from TRIM21 and 
its accumulation in the nucleus.  Nuclear GMPS drives the formation of a GMPS-
USP7-p53 complex, and stimulates p53 deubiquitylation by USP7. These results 
implicate a classic biosynthetic enzyme, associated with cell proliferation, in p53 
control.
 Several additional factors modulate p53 ubiquitylation and stability. 
Phosphorylation of p53 by ATM or Chk2 inhibits MDM2 binding and p53 
degradation (Banin et al., 1998; Shieh et al., 1997). In parallel, DNA damage 
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induced phosphorylation of MDM2 and MDM4 blocks binding of USP7, causing 
their destabilization (Maya et al., 2001; Meulmeester et al., 2005; Stommel and 
Wahl, 2004). Dephosphorylation of the specific isoform USP7S by PPM1G causes its 
downregulation and reduced levels of MDM2 (Khoronenkova et al., 2012). Another 
protein, TSPYL5 has been reported to with p53 for USP7 binding (Epping et al., 
2011). Finally, USP10 deubiquitylates and recycle p53 from the cytoplasm which 
has been exported from the nucleus (Yuan et al., 2010). These alternate factors 
notwithstanding, our knockdown experiments showed that they do not bypass 
the role of GMPS in p53 stabilization. GMPS does not appear to interact with these 
factors or MDM2 but target USP7 and p53 directly (Figure 1, Table S1).
 Recently, USP7 has emerged as a potential target for anti-cancer therapy. 
However, the role of USP7 in cancer is context-dependent and impinges on 
multiple tumor suppression pathways. Inactivation experiments in mice confirmed 
that regulation of p53 is a crucial, but not the only, function of USP7 (Kon et al., 
2010; Kon et al., 2011). Targeting of USP7 by the viral EBNA1 protein (Saridakis et 
al., 2005) or by cellular TSPYL5 (Epping et al., 2011) represses p53 function. In breast 
cancer, USP7 activity appears to help tumor suppression (Epping et al., 2011). In 
contrast, USP7 is overexpressed in prostate cancer and has been implicated in 
the inactivation of tumor suppression by PTEN (Song et al., 2008). Through its 
cooperation with Polycomb repressors, USP7 stimulates silencing of the p16INK4a 
tumor suppressor (Maertens et al., 2010). Inhibition of USP7 overcomes resistance 
to the proteasome inhibitor bortezomib in multiple myeloma cells (Chauhan et 
al., 2012). Finally, our results suggest that genotoxic drugs or nucleotide depletion 
can trigger, GMPS-dependent, stabilization of wild type p53 by USP7. Thus, when 
designing therapeutic strategies it is pertinent to take into account that USP7 
might either inhibit or stimulate different tumor pathways, depending on the type 
of cancer or drugs used.
Cytoplasmic-nuclear partitioning of GMPS is a crucial part of the switch 
for p53 stabilization. Ubiquitylation by TRIM21 determines GMPS localization 
in the cytoplasm. However, addition of the nuclear export inhibitor Leptomycin 
B to unstressed cells leads to strictly nuclear GMPS. This observation suggests 
cytoplasmic-nuclear shuttling of GMPS in which active export outcompetes import. 
Stress shifts the balance towards the accumulation of non-ubiquitylated GMPS in 
the nucleus, where it can bind USP7 and p53. TRIM21 is associated with Sjögren’s 
syndrome and systemic lupus erythematosus autoimmune diseases (Yoshimi et al., 
2012). In the immune system, TRIM21 controls interferon and pro-inflammatory 
cytokine expression via ubiquitylation of interferon regulating transcription 
factors and the NF-kB inhibitor IKKb. Our results suggest that TRIM21 may provides 
a connection between autoimmune diseases and p53 function.
 A cell’s proliferative ability is limited by its nucleotide pool. To support 
cell growth and rapid proliferation, cancer cells redirect glucose and glutamine 
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towards de novo nucleotide synthesis (Levine and Puzio-Kuter, 2010; Tong et al., 
2009). Enzymes such as GMPS and IMPDH are frequently upregulated in rapidly 
proliferating- and cancer cells (Jackson et al., 1975; Su et al., 2004; Weber, 1983). 
However, early oncogenic transformation may stimulate DNA replication in the 
absence of coordinate nucleotide synthesis, causing replicative stress and genomic 
instability (Bester et al., 2011). We now show that GMPS represents a direct 
molecular link between nucleotide biosynthesis and activation of the p53 tumor 
suppressor. Depletion of the GMPS substrate XMP triggers GMPS-mediated p53 
stabilization. Likewise, it will be interesting to explore the roles of GMPS and p53 
in the addiction of cancer cells to glutamine, another GMPS substrate. We found 
recently that Drosophila IMPDH, like GMPS, has a double function. In addition 
to XMP synthesis, IMPDH is a transcription factor that couples expression of E2f 
and histone genes to cellular state (Kozhevnikova et al., 2012). Our results suggest 
that selective biosynthetic enzymes that enable cell proliferation are enlisted to 
safeguard against unbalanced proliferation. This connection may provide novel 
opportunities for cancer therapy.
Experimental procedures
Antibodies: Polyclonal antibodies were generated by immunizing the rabbits or 
guinea pigs with GST-tagged proteins expressed in E. coli and affinity purified as 
described previously (Chalkley and Verrijzer, 2004). The following antigens were 
used, 1) USP7; mixture of peptides containing Full-length protein, N-terminus, 
amino acids (aa) 24-329 and C-terminus, aa 428-704, 2) GMPS; mixture of peptides 
N-terminus, aa 1-312 and C-terminus, aa 281-693, 3) p53; Full length protein, 4) 
MDM2; Full length protein and 5) TRIM21; Full length protein. The following 
antibodies were purchased as indicated. Anti-p53 (DO-1), anti-p53 (DO-7) and 
anti-TRIM21 (D-12) from Santa Cruz, anti-TRIM21 (Atlas antibodies), anti-Flag 
M2 antibodies (Sigma), anti-HA antibodies (Abcam) and anti-phospho H2A.x 
antibodies (JBW-301 clone, Millipore)
Imuunoprecipitations and massspectrometry (IP-massspec) and Co-
Imuunoprecipitations and Western blotting (Co-IPs): Immunopurifications were 
essentially carried out by using standard procedures as described earlier (Chalkley 
and Verrijzer, 2004). Briefly, whole cell extracts were prepared from U2OS or HEK-
293T cells either untreated or treated with 10 mM etoposide or 5 mg/ml MPA for 
24 hours. Cells were lysed in NET 0.1% buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 
5 mM EDTA, 0.1% Nonidet P40, freshly added 1 mM Phenyl Methyl Sulphonyl fluride, 
protease inhibitors, phosphatase inhibitors) and sonicated with a Bioruptor for 5 
min, 30-s ‘on’ and 1-min ‘off’ cycles. After removal of cell debris by centrifugation, 
cell lysates were incubated with affinity purified antibodies cross linked to Protein 
A-sepharose beads for three hours at 40 C. Beads were then subjected to extensive 
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washes for 5x5min with NET 0.1% buffer. Affinity purified proteins were then eluted 
with Glycine buffer pH 2.5 (100 mM Glycine, 150 mM NaCl). Eluted samples were 
TCA precipitated and dissolved in 1xSDS loading buffer and resolved by SDS-PAGE 
and proteins were identified by nanoflow liquid chromatography-tandem mass 
spectrometry. Similarly, Co-IPs were carried out by incubating 1 mg of cell lysates 
with 2-3 mg of antibody cross-linked to Protein A-agarose beads. Followed by 
extensive washes with NET 0.1% buffer, affinity purified proteins were then eluted 
with Glycine buffer pH 2.5. Eluted samples were TCA precipitated and dissolved in 
1x SDS loading buffer. Protein samples were resolved by SDS-PAGE and subjected 
to Western blotting analysis. 
Cell culture and lentiviral procedures: Cell culture was essentially carried out 
according to the standard procedures. Lentivirus expressing specific shRNA 
were purchased form shRNA library (Erasmus Centre for Biomics, Erasmus MC, 
Rotterdam, The Netherlands). High-titre viral stocks were produced in HEK-
293T cells by cotransfection of shRNA vector with packaging constructs by 
using standard transfection procedures. U2OS cells were then transduced with 
lentivirus expressing specific shRNA against GMPS, USP7, p53 and TRIM21 (See 
Supplementary Document S1 for shRNA sequences). Knockdowns were carried out 
for 4 days and the knockdown efficiency was analyzed either by immunobloting or 
by immunoflurescence. 
Cloning and transfection procedures: For transient expression in mammalian 
cells full-length cDNA of GMPS, USP7, p53 and TRIM21 were cloned into pQCXIP 
vector with flag-tag sequence or HA-tag sequence flanking at 5’ end. GMPSC114A, 
GMPS-K182R, K389R and K607R were generated by PCR based, site-directed 
mutagenesis. MDM2, His
6
-Ubiqutin and USP7C223S clones were as described earlier 
(van der Knaap et al., 2005). Transient transfections were carried out by using Fu-
Gene reagent, Roche diagnostics or PEI (Polyethylenimine) reagent, Sigma-Aldrich. 
Procedures followed were according to the manufacturer’s instructructions.
Real time quantitative PCR: Total RNA isolation, RT-qPCR, microarray experiments 
and data analysis were all performed by using standard procedures. See 
Supplementary Document S2 for primers details.
Immunofluorescence: Immunoflurescence was essentially carried out by using 
standard procedures. Briefly, cells grown as monolayer on cover slips were fixed 
by using 2% Para formaldehyde (PFA) or methanol and permeabalized by 0.2% 
Triton-X-100 solution for one hour on shaker incubator at room temperature. Then 
cells were incubated with primary antibody overnight at 40C on shaker incubator 
followed by three time washes. Then cells were incubated with secondary antibody 
for 30 minutes at room temperature followed by three time washes. Then cover 
slips were mounted by using mounting solution with DAPI and images were 
captured by using fluorescent microscope or confocal microscope.
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Supplementary 
Protein identity 
(MW in kDa)
flag-GMPS
GMPS (76) 2680 / 24.27 / 40 / 64.9 3581 / 66.5 / 52 / 77.3 de novo purine nucleotide biosynthesis
USP7 (128) 302 / 0.25 / 10 / 10.3 2258 / 3.83 / 47 / 50.8 ubiquitin specific protease 7
TP53 (44) 50 / - / 2 / 6.4 249 / 0.5 / 7 / 17.6 tumor suppressor p53
TRIM21 (52) 1685 / 8.8 / 26 / 50.3 358 / 0.58 / 9 / 20.2 tripartite motif 21; E3 ubiquitin ligase; autoantigen implicated in lupus 
erythematosus & Sjögren's syndrome autoimmune diseases
USP11 (110) 2087 / 2.8 / 32 / 42 126 / 0.1 / 4 / 4.9 ubiquitin specific protease 11
CAD (242) 2667 / 1.2 / 55 / 28 400 / 0.1 / 10 / 5.3 de novo pyrimidine nucleotide biosynthesis
IMPDH2 (55) 1162 / 3.6 / 20 / 43 167 / 0.2 / 6 / 16 de novo purine nucleotide biosynthesis; enzyme directly upstream of GMPS
HDAC6 (132) 1402 / 1.8 / 21 / 28.1
354 / 1.7 / 9 / 24
Histone deacetylase 6, cytoplasmic deacetylase; binds ubiquitinated proteins
WDR92 (84) 874 / 1 / 13 / 18 WD repeat domain 92
WDR82 (35)
563 / 4.1 / 13 / 40
WD repeat domain 82
EBNA1BP2 (34)
630 / 4.5 / 10 / 33
Epstein-Barr nuclear antigen 1 binding protein 2; negative regulator of p53
MAGEA1 (34) 408 / 1 / 8 / 20.7 melanoma antigen A-1
MAGEA4 (37) 233 / 0.6 / 5 / 14.5 melanoma antigen A-4
MAGED4 (81) 182 / 0.2 / 6 / 10 melanoma antigen D-4
MAGED2 (64) 117 / 0.12 / 4 / 7.6 melanoma antigen D-2, MAGE proteins are cancer antigens; selective 
MAGE proteins bind and stimulate RING ubiquitin ligases
SSB (46) 387 / 1.1 / 9 / 21 182 / 0.2 / 6 / 10 Sjögren's syndrome antigen B
PDRG1 (15) 273 / 4.9 / 6 / 36 337 / 0.37 / 7 / 11 p53 and DNA-damage regulated 1
MRE11A (81) 191 / 0.2 / 5 / 8.4
RAD50 (138) 189 / 0.1 / 5 / 8.4
337 / 0.3 / 7 / 11 subunit MRN complex; double-strand break repair
188 / 0.1 / 6 / 5.5 subunit MRN complex; double-strand break repair
NBS1 (85) 44 / 0.04 / 1 / 1.5 Nibrin, subunit MRN complex; double-strand break repair
comments
GMPS
MS/ ES./ UP/ % C MS/ ES./ UP/ % C
Table S1; Massspecrtometric analysis of GMPS immunopurifications, Related to Figure 1 
Details of Massspecrtometric analysis such as, Mascot score (MS), emPAI score (ES), Unique 
peptides (UP) and % coverage (%C) are given in the table.  GMPS immunopurifications 
identified USP7, p53 and TRIM21 as interacting proteins. We also found Melanoma antigen 
A, 1 (MAGE A1) and A, 4, (MAGE A4), MAGE proteins were shown to be in complex with TRIM 
E3 ubiquitin ligases (Doyle et al., 2010). We also found Sjogren syndrome antigen B is an 
autoantigen found in patients with Sjogren syndrome (Hennig et al., 2008). Among others, 
we found deubiquitinase USP11, USP7 and USP11 are implicated in polycomb-mediated 
regulation of INK4a tumor suppressor locus. However, USP11 was shown to have no effect 
on p53 stability or deubiquitylation (Li et al., 2002; Maertens et al., 2010). Also, we found that 
USP11 does not have any effect on GMPS deubiquitylation or subcellular localization (data 
not shown). We also found nucleotide biosynthetic enzymes such as, CAD, and IMPDH2. Also, 
histone deacetylase, HDAC6, WD repeat proteins WDR82 and WDR92. Apart from this, we 
also found Epstein bar virus nuclear antigen 1 binding protein 2 (EBNA1BP2), it has been 
shown that EBNA1 recruits GMPS-USP7, complex to repress Epstein bar virus latent origin of 
replication.  We also found DNA damage response proteins such as p53 and DNA damage 
regulated 1 (PDRG1), MRE11, RAD50 and Nibrin, MRN complex.
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Figure S1; Lentiviral-mediated knockdown of GMPS, USP7, p53 to check antibody 
specificity, Related to Figure 1, 2, 3 & 4 
A-F) U2OS cells were transduced with lentivirus encoding specific shRNA against GMPS 
or USP7 or p53. Followed by cells were either untreated or treated with 10mM etoposide 
for 24 hours as indicated. Cells were then subjected to either Western blotting analysis or 
immunofluoroscence using the antibodies as indicated. Images were captured by using 
fluorescent microscope.
G&H) MDA-231 cells were transduced with lentiviral encoding specific shRNA against GMPS 
or USP7 or p53. Followed by cells were subjected to either Western blotting analysis or 
immunofluoroscence using the antibodies as indicated. Images were captured by using 
fluorescent microscope.
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Figure S2; USP7 and p53 does not affects 
GMPS sub-cellular localization, Related to 
Figure 5
U2OS cells grown as a monolayer on cover 
slips were transduced with lentivirus 
expressing either non-targeted shRNA 
(mock) or shRNA against USP7 (A) or p53 
(B) for 72 hours. Followed by cells were 
either untreated (UNT) or treated with 10mM 
etoposide (ETO) for 24 hrs. Cells were stained 
by using specific antibodies as indicated. 
Images were captured by using fluorescent 
microscope.
 
 
Figure S3; Ubiquitylation by TRIM21 
is essential for GMPS cytoplasmic 
localization, Related to Figure 6
 HEK-293T cells were transiently 
transfected with flag-GMPS with His
6
-Ub 
or with TRIM21 or with His
6
-Ub and HA-
TRIM21 for 48 hours. Followed by cells 
were either subjected to Western analysis 
(A) or immunofluoroscence (B) using the 
antibodies as indicated. Images were 
captured by using confocal microscope.
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Document S1; shRNA target sequences, Related to Figure 2 & 4:
USP7: CCAGCTAAGTATCAAAGGAAA, CGTGGTGTCAAGGTGTACTAA
GMPS: GCATTTGCTATAAAGGAACAA, CCTACAGTTACGTGTGTGGAA
p53: GTCCAGATGAAGCTCCCAGAA
TRIM21: TGAGAAGTTGGAAGTGGAAAT, GAGTTGGCTGAGAAGTTGGAA
Document S2; Primers used for RT-qPCR, Related to Figure 2:
p53: CCTCCTCAGCATCTTATCCGA & CATAGGGCACCACCACACTA  
p21: TGTGGACCTGTCACTGTCTTG & CGGCGTTTGGAGTGGTAGAA  
BAX: GCTTCAGGGTTTCATCCAGG & GCTCAGCTTCTTGGTGGA    
CDC6: GCTGTCTCGGGCATTGAACAA & CATAGGTTGTCATCGCCCAG
MCM6: GAGTTTCAGAGCAGCGATGG & GGTGGTGGAAAGTTGCTGGTT
GAPDH: GGATTTGGTCGTATTGGGCG & TCCTGGAAGATGGTGATGGGA
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ATP-dependent chromatin-remodeling complexes (remodelers) are essential regulators of chromatin struc-
ture and gene transcription. How remodelers can act in a gene-selective manner has remained enigmatic. A
yeast two-hybrid screen for proteins binding the Drosophila transcription factor Tramtrack69 (TTK69) iden-
tified MEP1. Proteomic characterization revealed that MEP1 is a tightly associated subunit of the NuRD
remodeler, harboring the Mi2 enzymatic core ATPase. In addition, we identified the fly homolog of human
Deleted in oral cancer 1 (DOC1), also known as CDK2-associated protein 1 (CDK2AP1), as a bona fide NuRD
subunit. Biochemical and genetic assays supported the functional association between MEP1, Mi2, and TTK69.
Genomewide expression analysis established that TTK69, MEP1, and Mi2 cooperate closely to control tran-
scription. The TTK69 transcriptome profile correlates poorly with remodelers other than NuRD, emphasizing
the selectivity of remodeler action. On the genes examined, TTK69 is able to bind chromatin in the absence of
NuRD, but targeting of NuRD is dependent on TTK69. Thus, there appears to be a hierarchical relationship
in which transcription factor binding precedes remodeler recruitment.
Chromatin is the natural template of the eukaryotic tran-
scription machinery. Consequently, regulation of gene ex-
pression involves the interplay between sequence-specific
transcription factors, the basal machinery, coregulators, and
enzymes that modulate chromatin structure. ATP-dependent
chromatin-remodeling factors (remodelers) constitute one class
of enzymes that target chromatin. The basic biochemical ac-
tivity of remodelers is to use the energy of ATP hydrolysis to
move or eject nucleosomes (8). Although their in vitro activity
might suggest that remodelers act in a generic way, it has
become clear that different remodelers perform distinct, non-
redundant functions. An early example of functional special-
ization was our finding that the Brahma (BRM) remodeling
complexes, but not ISWI remodelers, act as chromatin-specific
coactivators for the transcription factor ZESTE (15). Con-
versely, unlike ISWI, the BRM remodelers were unable to
order a nucleosomal array. Moreover, several studies have
demonstrated that different remodelers control distinct biolog-
ical processes (4, 8, 24).
Currently, four major classes of remodelers are recognized,
based on their ATPase and accessory subunits (8). These com-
prise the SWI/SNF, ISWI, CHD, and INO80 families. Mi2
(also known as CHD4) is the founding member of the CHD
family of remodelers, characterized by the presence of a tan-
dem chromodomain in the ATPase subunit (9). A unique as-
pect of NuRD is its coupling of remodeling and histone
deacetylase (HDAC) activities in one complex. Although there
is some variability between the various vertebrate NuRD com-
plexes described so far, the key subunits of NuRD are the Mi2
ATPase, the protein deacetylases HDAC1 and HDAC2,
metastasis-associated proteins MTA1, MTA2, and MTA3, the
retinoblastoma-associated histone binding proteins RBP46
and RBP48, p66/68, and MBD2 and MBD3, harboring a
methyl CpG binding domain (9). These vertebrate proteins
have highly conserved Drosophila counterparts. However, to
date, Drosophila NuRD has not been purified as a defined
entity. Instead, a two-subunit complex comprising Mi2 and the
fly homolog of the Caenorhabditis elegans Mog interacting,
ectopic P granulocyte 1 (MEP1) protein has been isolated from
Drosophila Kc cells (17). Thus, the identity of Drosophila
NuRD has remained unclear.
Mi2 and NuRD play important roles in cell fate control
during development. For example, the C. elegans homologs of
Mi2 and MEP1 cooperate to maintain the distinction between
germ line and soma in developing embryos by inhibiting the
expression of germ line-specific genes in somatic cells (32).
During lymphocyte development in mammals, NuRD acts as a
corepressor for the BTB/POZ domain and the zinc finger tran-
scription factor BCL6, repressing plasma cell-specific genes so
as to promote differentiation toward B cells (11). In Drosoph-
ila, Mi2 has been implicated in the repression of homeotic
genes by the GAP protein Hunchback (16). Moreover, the
repression of proneural genes by the transcription factor
Tramtrack69 (TTK69) so as to block a neuronal cell fate is
dependent on Mi2 (27, 40). Indeed, Mi2 was identified as an
* Corresponding author. Mailing address: Department of Biochem-
istry, Center for Biomedical Genetics, Erasmus University Medical
Center, Rotterdam, Netherlands. Phone: 31-10-408-7461. Fax: 31-71-
527-6284. E-mail: c.verrijzer@erasmusmc.nl.
† Supplemental material for this article may be found at http://mcb
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‡ B.A.R. and P.K.B. made equal contributions and should both be
considered first authors.
 Published ahead of print on 23 August 2010.
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interacting partner of TTK69 in a two-hybrid screen, and the
two proteins colocalize on many loci on third-instar larval
polytene chromosomes (27). Thus, Mi2 appears to act as tran-
scriptional corepressor for TTK69.
TTK is an important Drosophila transcription factor, which
is involved in various aspects of development and cell differ-
entiation. As a result of alternative splicing, the ttk locus en-
codes two isoforms, TTK69 and TTK88. These proteins have
different C-terminal zinc finger DNA-binding domains but
share an N-terminal BTB/POZ protein-protein interaction do-
main (5, 14, 28, 39). TTK was first identified as a repressor of
the pair-rule genes even skipped and fushi tarazu (5, 14) but is
involved in numerous additional processes. For example, TTK
controls selective cell fate decisions in the developing embry-
onic nervous system, in photoreceptor differentiation, and in
sensory organ precursor differentiation (1, 3, 12, 13, 18, 21, 30,
37–39). During eye development, TTK blocks the differentia-
tion of precursor cells to photoreceptors and promotes specific
nonneuronal fates, such as cone cells. TTK is regulated post-
translationally through ubiquitin-mediated degradation trig-
gered by the E3 ubiquitin ligase SINA, which is itself con-
trolled by RAS-mitogen-activated protein (MAP) kinase
signaling (21, 30). This ubiquitin-dependent developmental
switch depends on the balance between the antagonistic activ-
ities of the deubiquitylating protease UBP64 and SINA (2).
Here we explored the interplay between the sequence-spe-
cific transcription factor TTK69 and the remodeler NuRD. A
yeast two-hybrid screen identified MEP1 as a TTK69 partner.
Our proteomic characterization of NuRD established MEP1
and fly CDK2AP1/DOC1 as bona fide subunits. TTK69 inter-
acts genetically and functionally with both MEP1 and Mi2. We
performed a genomewide expression analysis to determine the
transcriptional circuitries controlled by TTK69 and NuRD.
Their substantial overlap suggests that TTK is an important
factor recruiting NuRD to its targets. Our analysis of chroma-
tin association suggests a hierarchical relationship in which
TTK69 recruits NuRD rather than the remodeler facilitating
TTK69 binding.
MATERIALS AND METHODS
Protein-protein interaction assays. Yeast two hybrid screens were performed
as described previously (27) using a full-length TTK69 cDNA cloned into
pLexA202 to screen a 0- to 24-h Drosophila embryonic cDNA library fused to the
B42 activation domain in plasmid pJG4-5. Domain mapping was performed by
using TTK69 deletion constructs cloned into pLexA202 and tested for their
interaction with MEP1 residues 257 to 536 fused to the B42 activation domain in
plasmid pJG4-5. The strength of interaction was tested by both colony growth
and -galactosidase assays (27). For glutathione S-transferase (GST)-tagged
interaction assays, radiolabeled proteins were produced using the TnTQuick
system (Promega) with the pLinkT7 vector. Glutathione beads containing 5 to
10 g of the appropriate GST fusion protein made up to a 30-l volume were
mixed with 25 l of the TnT reaction mixture and 50 l of 2 pulldown buffer
(40 mM Tris-HCl [pH 8], 200 mMNaCl, 800 mM KCl, 0.2% Triton X-100, 1 mM
phenylmethylsulfonyl fluoride [PMSF], protease inhibitors), and the mixture was
incubated at 4°C for 2 h. The beads were transferred to MobiCol columns
(MoBiTec/VH Bioscience) and were washed 4 times with 1 pulldown buffer.
Bound proteins were eluted by addition of 20 l 3 sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) loading buffer and boiling. A
10-l volume of the resulting mixture, along with the input material, was ana-
lyzed by SDS-PAGE.
Antibodies, immunological procedures, protein purification, and mass spec-
trometry. Polyclonal antibodies were generated by immunizing guinea pigs with
GST fusion proteins expressed in Escherichia coli and were affinity purified as
described previously (7). The following antigens were used: Mi2 amino acids (aa)
1290 to 1533, MTA1-like aa 132 to 476, MEP1 aa 681 to 800, TTK69 aa 333 to
546, and the full-length CG18292 (CDK2AP1/DOC1) protein. Immunization
and affinity purification were carried out as described previously (7). Rabbit
polyclonal antibodies against TTK69 (27) and ISWI (6) have been described
previously. Coimmunoprecipitations (coIPs), immunoblotting, and immunolo-
calization on 3rd-instar larval salivary gland polytene chromosomes were per-
formed as described previously (6). Embryo nuclear extracts were prepared from
0- to 12-h-old Drosophila embryos. Immunopurification procedures using affin-
ity-purified antibodies directed against Mi2 or MEP1 and mass spectrometric
analysis were all performed as described previously (6, 7). After affinity purifi-
cation, beads were washed twice with HEMG buffer (25 mM HEPES-KOH [pH
7.6], 0.1 mM EDTA, 12.5 mM MgCl2, 10% glycerol, 0.1% NP-40, and a cocktail
of protease inhibitors) containing 200 mM KCl (HEMG/200), 5 times with
HEMG/500, once with HEMG/200, and finally once with HEMG/200 lacking
NP-40. Typical contaminants, also present in the products of immunopurification
using beads coated with preimmune serum or antibodies directed against unre-
lated proteins, were omitted from Table 1. Immunodepletion was performed
essentially as described previously (7), with the following adaptations. The nu-
clear extract was diluted with HEMG/100 to a final total protein concentration of
5 mg/ml and was then cleared by centrifugation. This extract was then incubated
with protein A beads cross-linked with either anti-CDK2AP1/DOC1 (-
CDK2AP1/DOC1) antibodies or preimmune serum (mock control). After 2 h,
the beads were removed by centrifugation. These steps were repeated 3 more
times. Supernatants were then resolved by 8% SDS-PAGE and were analyzed by
immunoblotting.
Drosophila genetics. All fly stocks were maintained under standard conditions,
and crosses were performed using standard procedures. RNA interference
(RNAi) lines (10) for MEP1 (strain 24533), Mi2 (strain 10766), and TTK69
(strain 10855) were obtained from the Vienna Drosophila RNAi Centre (http:
//stockcenter.vdrc.at). The GMR-Gal4 enhancer line was obtained from the
Bloomington Drosophila Stock Center at Indiana University (http://flystocks.bio
.indiana.edu/). All crosses were performed at 25°C and were repeated several
times. Representative examples are shown in Fig. 3.
RNAi, genomewide expression analysis, and ChIP-qPCR. RNAi in Drosophila
S2 cells, RNA isolation, reverse transcription-quantitative PCR (RT-qPCR),
microarray experiments, and data analysis were all performed as described pre-
viously (26). Details are available upon request. Chromatin immunoprecipitation
(ChIP)-qPCR assays were performed, and results were quantified, as described
previously (22, 25). Immunoprecipitations were performed with the following
antibodies: -Mi2, -MEP1, -TTK69, and -BAP111 (6). Briefly, Drosophila S2
cells were cultured in Schneider’s medium (catlog no. 21720-024; Invitrogen) and
treated with double-stranded RNA (dsRNA) for 4 days. Double-stranded RNAs
were synthesized using an Ambion Megascript T7 kit. RNA samples from three
fully independent experiments were prepared and analyzed by RT-qPCR. Cross-
linked chromatin was prepared from S2 cells and was sheared by sonication to an
average length of 0.5 kbp. Chromatin was then incubated with the antibodies
indicated in Fig. 6. Background ChIP levels, subtracted during data processing,
were determined by using beads lacking specific antibodies. Following IP, the
recovered DNA was analyzed by qPCR with SYBR green I, using the MyiQ
single-color real-time PCR detection system (Bio-Rad). The data presented are
the results of three independent biological replicate experiments.
ChIP primers were as follows: for ARK, 5-ACCTGGCAGTGAATACCTTT
GTTG-3 and 5-GTGTGACCATATTGAGCCGTATCG-3; for Hairy, 5-GA
GCCGCAGATACACAGTACACAG-3 and 5-GCCGTTCGTGGTTTGCTG
ATTC-3; for Engrailed, 5-GAGCCACTGATTCTTCTG-3 and 5-TGTCGG
AACAACAGTTGC-3; for Sk1, 5-AAAGCAAAGGCAAAAGCAACAG-3
and 5-GAGGGTGAACTAACCTTATTTTCC-3; and for KCNQ, 5-CGTTG
TGGGCGGGTCAGG-3 and 5-TATTTGGGTTGTTGGGGTATGGC-3. All
other primer sequences will be made available upon request.
Microarray data accession number. Raw expression data have been submitted
to the ArrayExpress database (Microarray Informatics Team, EMBL) under
accession no. E-TABM-1010 (http://www.ebi.ac.uk/microarray-as/ae/).
RESULTS
Transcription factor TTK69 binds the NuRD subunit MEP1.
Previously, we published a yeast two-hybrid screen that re-
sulted in the identification of Mi2 as a TTK69-binding factor
(27). Here we report an extension of this screen. Using full-
length TTK69 as the bait, we isolated a partial cDNA encoding
aa 257 to 536 of Drosophila MEP1, a 1,152-aa protein harbor-
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ing multiple potential C2H2 zinc fingers and SUMO-interact-
ing motifs (Fig. 1A). To delineate the MEP1-binding domain
of TTK69, we again utilized the two-hybrid assay. Surprisingly,
we found that the same region that mediates Mi2 binding also
suffices to recruit MEP1 (Fig. 1B) (27). A minimal binding
region of about 100 amino acids (aa 392 to 500) is located
directly upstream of the zinc fingers of TTK69 and is absent in
TTK88. The other portions of TTK69 do not display robust
binding to either MEP1 or Mi2. As an independent assay, we
tested the ability of recombinant 35S-labeled TTK69 to bind
GST-tagged MEP1 (Fig. 1C). TTK69 associates efficiently with
immobilized MEP1 but does not bind GST. Together, our
results suggest that TTK69 binds MEP1 directly.
To determine the interaction network of MEP1, we took a
proteomics approach to make an inventory of its associated
proteins in Drosophila embryo nuclear extracts. Nuclear ex-
tracts were incubated with protein A Sepharose beads coated
with affinity-purified antibodies directed against MEP1. Fol-
lowing extensive washes with a buffer containing 500 mM KCl
and 0.1% NP-40, bound and unbound material was resolved by
SDS-PAGE, followed by Coomassie staining (Fig. 2A). Mass
spectrometric analysis suggested that MEP1 is tightly associ-
ated with the full NuRD complex and with TTK69 (Fig. 2A
and Table 1). No binding to the control beads occurred. Thus,
in contrast to MEP1 isolated from Kc cells, which binds only
Mi2 (17), our purification from embryo nuclear extracts sug-
gests that MEP1 is part of NuRD. In parallel, we used affinity-
purified antibodies directed against Mi2 to purify NuRD (Fig.
2B). Again, our mass spectrometric analysis revealed the pres-
ence of MEP1, all core NuRD subunits, and TTK69 (Fig. 2B
and Table 1). No peptides unique for TTK88 were identified in
the MEP1 or Mi2 purification. Our results suggest that Dro-
sophila NuRD comprises Mi2, MEP1, MTA1, p66/68-like,
RPD3, CAF1 p55 (the homolog of RbAp46/48), MBD-like
protein isoforms A and B, and the fly homolog of CDK2-
associated protein 1 (CDK2AP1). CDK2AP1 is a potential
tumor suppressor also known as DOC1 (deleted in oral cancer
1) (31). Although not generally listed as such, CDK2AP1/
DOC1 was identified previously as a protein associated with
mammalian NuRD (19). Our independent identification of
CDK2AP1 in Drosophila NuRD suggests that it might, in fact,
be an overlooked subunit of NuRD. Finally, in our immuno-
purifications, we detected TTK69, confirming its binding to
NuRD. However, based on its modest scores in the mass spec-
trometric analysis, we consider TTK69 a substoichiometric in-
teracting factor and not a NuRD subunit.
As an additional comparison of MEP1- and Mi2-associated
factors, we performed coimmunoprecipitations (coIPs) from
embryo nuclear extracts (Fig. 2C). Western immunoblotting
confirmed the stable association of Mi2, MEP1, MTA1,
CDK2AP1/DOC1, RPD3, and TTK69. BRM and ISW1 acted
as negative controls, demonstrating the specificity of the coIPs.
To obtain additional evidence that CDK2AP1/DOC1 is a core
NuRD subunit, we performed coIPs using antibodies directed
against this protein (Fig. 2D). Indeed, anti-CDK2AP1/DOC1
antibodies efficiently purified the NuRd complex, as illustrated
by the copurification of Mi2, MEP1, MTA1, and RPD3. To
investigate whether the majority of NuRD would be associated
with CDK2AP1/DOC1, we immunodepleted an embryo nu-
clear extract using antibodies directed against this protein.
Inspection of the CDK2AP1/DOC1-depleted extract revealed
the concomitant loss of Mi2, MEP1, MTA1, and, to a some-
what lesser extent, RPD3 (Fig. 2E). In contrast, ISWI levels
were not affected.
Collectively, our proteomic analysis, coIPs, and immune de-
pletion experiments provide compelling evidence that MEP1
and CDK2AP1/DOC1 are tightly associated subunits of Dro-
FIG. 1. TTK69 binds Drosophila MEP1. (A) A yeast two-hybrid
screen identified Drosophila MEP1 (CG1244) as a TTK69-interacting
protein. TTK69 interacts with MEP1 aa 257 to 536, encoded by a
partial cDNA that was expressed fused to the activation domain (AD)
in the original screen. The potential C2H2 zinc fingers are indicated.
(B) A series of TTK69 truncation constructs fused to the LexA DNA-
binding domain were used to map the MEP1-binding domain. The
BTB/POZ domain, the double zinc finger DNA-binding domain, and
the PEST domain are diagramed. Dark green indicates the TTK69
sequence; light green, the sequence shared with TTK88. A region
spanning aa 317 to 500 retained full MEP1-binding activity. Amino
acids 392 to 500 bound somewhat more weakly but still displayed
robust binding to MEP1. The same constructs have been used previ-
ously to delineate the Mi2 binding domain (27), revealing an overlap
between the MEP1 and Mi2 binding regions of TTK69. Representative
streaks of yeast expressing the two-hybrid fusions are shown. The
relative interaction strengths are indicated as follows:, no detectable
interaction; (), very weak; , weak; , strong; , very strong.
(C) TTK69 binds MEP1 directly. [35S]methionine-labeled full-length
TTK69 was incubated with either GST-MEP1 aa 257 to 536 or GST
alone. Following washes, bound material was resolved by SDS-PAGE
and visualized by autoradiography. Duplicate samples and 10% of the
input were loaded.
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sophila NuRD. The composition of fly NuRD, based on our
analysis, is diagramed in Fig. 2F. The results from our two-
hybrid screen, in vitro interaction assay, proteomic survey, and
coIPs all support the conclusion that TTK69 binds MEP1 di-
rectly. These findings suggest that MEP1 might act as a bridg-
ing factor between the DNA-binding transcription factor
TTK69 and NuRD.
TTK69, MEP1, and Mi2 interact genetically. To comple-
ment our biochemical results and establish the in vivo signifi-
cance of the interactions between TTK69, MEP1, and Mi2, we
FIG. 2. MEP1 and CDK2AP1/DOC1 are Drosophila NuRD subunits. (A and B) Immunopurification (IP) of MEP1 (A) and Mi2 (B) from
embryo nuclear extracts. Embryo nuclear extracts were incubated with protein A-Sepharose beads coated with either a control (anti-GST) antibody
(mock) or an affinity-purified anti-MEP1 or anti-Mi2 antibody. Input, unbound material, and proteins retained on the beads after extensive washing
were resolved by SDS-PAGE and visualized by Coomassie staining. Bands were excised, and proteins were identified by nanoflow liquid
chromatography-tandem mass spectrometry. The mass spectrometry scores of the indicated proteins are listed in Table 1. (C) Coimmunopre-
cipitations of NuRD and TTK69 with MEP1. Embryo nuclear extracts were incubated either with preimmune serum (mock) or with an anti-Mi2
or anti-MEP1 antibody. Immunopurified proteins were resolved by SDS-PAGE and analyzed by immunoblotting using the indicated antibodies.
Ten percent of the input material was loaded for reference. (D) CDK2AP1/DOC1 is a NuRD subunit. Results of coIPs using anti-CDK2AP1/
DOC1 antibodies are shown. (E) The majority of NuRD is stably associated with CDK2AP1/DOC1. Nuclear extracts were immunodepleted with
beads that were coated either with preimmune serum (mock) or with an antibody directed against CDK2AP1/DOC1. The supernatants were then
resolved by SDS-PAGE and analyzed by Western immunoblotting with the indicated antibodies. Whereas NuRD subunits were strongly depleted,
ISWI remained unaffected. Because RPD3 is part of multiple complexes, its depletion is expected to be less complete. (F) Cartoon summarizing
our proteomic results. Drosophila NuRD comprises the ATPase Mi2, the HDAC RPD3, MTA1-like, CAF1 p55, p66/68-like, MBD-like isoforms
A and B, MEP1, and CDK2AP1/DOC1. We note that mammalian CDK2AP1 was identified previously as a mammalian NuRD-associated protein
by Le Guezennec et al. (19). We failed to detect additional proteins that have been reported incidentally as binding to NuRD. We do not consider
TTK69 a NuRD subunit, although this cannot be formally concluded from the proteomics results. Rather, we view TTK69 as a transcription factor
that interacts with NuRD by binding MEP1 and Mi2.
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employed a genetic assay. We took advantage of the availabil-
ity of fly lines expressing interfering RNA (RNAi) targeting
TTK69, MEP1, or Mi2 (10). RNAi expression in these lines is
under the control of the GAL4-upstream activation sequence
(UAS) system, allowing the use of specific drivers to direct
tissue-specific knockdowns. To lower TTK69, MEP1, or Mi2
levels in the developing eye, we used glass multiple reporter
(GMR)-GAL4 to drive RNAi expression. Depletion of
TTK69 (GMRTTK69RNAi), MEP1 (GMRMEP1RNAi) or
Mi2 (GMRMi2RNAi) alone had only a slight effect on eye
development and ommatidial arrangement (Fig. 3A to D).
However, the combined reduction of TTK69 and MEP1 (Fig.
3E) strongly affected ommatidial organization and caused a
clear rough-eye phenotype. Likewise, the combined reduction
of MEP1 and Mi2 synergistically affected eye development
(Fig. 3F). These genetic interactions demonstrate that TTK69,
MEP1, and Mi2 interact and cooperate in vivo.
TTK69, MEP1 and Mi2 control overlapping transcriptomes.
To compare the genomewide binding pattern of TTK69 versus
the NuRD subunits MEP1 and Mi2, we determined their dis-
tributions on larval salivary gland polytene chromosomes (Fig.
4). TTK69 colocalizes with MEP1 and Mi2 on a significant
portion of their chromosomal binding sites. However, it is also
clear that there are NuRD sites that lack TTK69 and, vice
versa, that there are loci bound by TTK69 that are devoid of
NuRD. We conclude that whereas TTK69 and NuRD also
occupy unique loci, they colocalize on a substantial number of
their binding sites.
To investigate the level of transcriptional coregulation by
TTK69, MEP1 and Mi2, we combined RNAi-mediated deple-
tion with genomewide expression analysis. We treated S2 cells
with dsRNA directed against TTK69, MEP1, or Mi2. Immu-
noblot experiments showed that loss of TTK69 did not affect
the stability of the NuRD subunit Mi2, MEP1, or RPD3 (Fig.
5A). Likewise, depletion of Mi2 or MEP1 left TTK69 levels
unchanged. However, depletion of MEP1 did cause a reduc-
tion in Mi2 levels, whereas loss of Mi2 did not affect MEP1.
RPD3 levels were unaffected by depletion of Mi2, MEP1, or
TTK69. ISWI and tubulin acted as loading controls. Next, we
extracted RNA from these cells or mock-treated cells. For
each subunit, we performed three fully independent RNAi-
mediated depletion experiments using distinct cell batches. For
comparison, we used the expression analysis of cells depleted of
ISWI, SNR1, Moira (MOR), or BRM (26). BRM, MOR, and
SNR1 are three common core subunits of the BAP and PBAP
remodelers, which represent the SWI/SNF class in Drosophila.
The ISWI ATPase forms the enzymatic core of the ISWI class of
remodelers, comprising NuRF and ACF/ChRAC.
The extracted RNA was labeled and hybridized with Affy-
metrics Drosophila Genome 2 arrays. Analysis of the expres-
sion data was performed as described previously (26). We used
an unbiased statistical analysis of the whole data set to com-
pare the impacts of the various proteins on gene expression.
Hierarchical agglomerative clustering derived from Spear-
man’s correlation analysis revealed a striking correlation be-
tween the effects of MEP1, Mi2, or TTK69 depletion. In con-
trast, neither ISWI depletion nor loss of (P)BAP subunits
correlated well with the TTK69/NuRD cluster. Another way to
uncover relationships between the gene expression profiles of
different regulators is the application of principal-component
analysis (PCA). PCA is a linear transformation that finds and
projects original variables to the minimal principal compo-
nents (PCs) that account for the maximal variance in the data
set. About 76% of the variance in transcriptomes obtained
after depletion of the 7 proteins analyzed here is explained by
PC1 to PC3. Figure 5C shows the close clustering of the
TTK69, Mi2, and MEP1 expression profiles, reflecting their
high degree of correlation. The profiles of the (P)BAP core
subunits and of ISWI were clearly separated from the TTK69/
NuRD cluster, reflecting the fact that each regulates a specific
set of genes.
Venn diagram analysis of genes that were affected signifi-
cantly by the knockdowns demonstrates the substantial overlap
between the TTK69-, MEP1-, and Mi2-dependent transcrip-
TABLE 1. Mass spectrometric analysis of MEP1- and Mi2-associated proteins purified from Drosophila embryo nuclear extracts
Protein identity Mol mass(kDa)
MEP1 Mi2
CommentsaMascot
score
emPAI
score
No. of
unique
peptides
%
Sequence
coverage
Mascot
score
emPAI
score
No. of
unique
peptides
%
Sequence
coverage
Mi2 (CG8103) 225 8,311 11.87 98 54.1 9,323 14.83 112 62.1 ATPase, NuRD enzymatic core
MEP1 (CG1244) 175 3,817 9.97 40 53.2 3,315 6.02 37 46.3 Zinc fingers, SUMO
interaction motifs
MTA1-like (CG2244) 97 2,610 3.94 39 55 3,047 6.77 43 59.1 Metastasis-associated protein
p66/68-like (CG32067) 95 2,229 2.33 22 48.1 2,480 2.24 24 48.8 Transcriptional corepressor
RPD3 (CG7471) 58 1,617 7.80 20 51.2 1,279 3.1 17 44.9 Histone deacetylase
p55 CAF1 (CG4236) 48 1,316 2.95 14 52.3 1,354 3.04 15 50.9 Histone binding
MBD-like A (CG8208-PA) 36 888 4.2 11 36.6 461 0.8 8 41.9 Methyl-CpG binding domain-
like isoform A
MBD-like B (CG8208-PB) 25 481 2.69 7 46.5 300 0.92 5 31.4 Methyl-CpG binding domain-
like isoform B
CDK2AP1/DOC1
(CG18292)
29 815 3.91 8 52 816 1.98 9 44.1 CDK2-associated protein 1;
deleted in oral cancer 1
TTK69 (CG1856) 69 478 0.28 7 21.8 70 0.08 1 5.4 POZ domain, Zn finger DBD,
sequence-specific
transcriptional repressor
MAD (CG2662) 50 681 1.09 9 34.5 SMAD transcription factor
dCtBP (CG7583) 42 891 2.03 12 41.5 Transcriptional corepressor
Nejire/CBP (CG15319) 343 1,044 0.16 17 9.8 Histone acetyltransferase and
coactivator
a DBD, DNA binding domain.
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tomes (Fig. 5D). Consistent with the well-established repres-
sive functions of TTK69 and NuRD, roughly twice as many
genes were upregulated as downregulated following depletion
of TTK69, MEP1, or Mi2. Nonetheless, our results raise the
possibility of a role for TTK69 and NuRD in gene activation as
well as repression, although the latter function clearly appears
to be more prevalent. Alternatively, the activating role of
TTK69 and NuRD might be indirect, i.e., due to repression of
anther repressor. Gene Ontology (GO) analysis revealed the
strong overrepresentation of developmental signaling in pro-
cesses regulated by TTK69 and NuRD (Fig. 5E). A striking
feature of the GO category grouping is that whole classes of
genes appear to be either mostly repressed or mostly activated,
suggesting coordinate regulation. In conclusion, our genome-
wide analysis revealed substantial overlap between the TTK69,
MEP1, and Mi2 transcriptomes, confirming that these factors
collaborate closely.
TTK69 recruits NuRD to selective loci. Does NuRD first
open up chromatin to allow sequence-specific DNA-binding by
TTK69? Or does TTK69 bind chromatin independently, fol-
lowed by NuRD recruitment? To distinguish between these
two scenarios, we combined RNAi-mediated knockdown in S2
cells with chromatin immunoprecipitations quantified by real-
time PCR (ChIP-qPCR). All our ChIP data are the results of
at least three fully independent biological replicates. Chroma-
tin was extracted from S2 cells that were either mock treated or
depleted of TTK69, MEP1, or Mi2 (Fig. 5A). For ChIP-qPCR
analysis, we examined binding to the regulatory regions of
three representative TTK69 target genes: Hairy, Engrailed
(En), and Apaf1-related-killer (ARK; CG6829). The first two are
classic TTK69-regulated genes, and ARK was identified as one
of the potential targets of TTK69 and NuRD in our genome-
wide expression analysis.
First, we confirmed the derepression of Hairy, En, and ARK
after TTK69, MEP1, or Mi2 knockdown by qPCR on mRNA
isolated from S2 cells (Fig. 6A). ChIPs using antibodies against
TTK69 revealed that depletion of either MEP1 or Mi2 did not
affect TTK69 binding (Fig. 6B). As expected, TTK69 knock-
down led to a loss of the TTK69 ChIP signal. The (P)BAP
target SK1 served as a negative control and was not bound by
TTK69. These results show that the binding of TTK69 to the
DNA loci tested is independent of chromatin remodeling by
NuRD. ChIPs using antibodies against Mi2 revealed strongly
reduced promoter binding due to a loss of TTK69, MEP1, or
Mi2 itself (Fig. 6C). Because knockdown of MEP1 also caused
a reduction in Mi2 protein levels (Fig. 5A), we cannot distin-
guish between loss of Mi2 and loss of recruitment. Like Mi2
binding, MEP1 binding was strictly dependent on TTK69 (Fig.
6D). However, loss of Mi2 only modestly affected MEP1 re-
cruitment, suggesting that TTK69 can recruit MEP1 directly
and independently of Mi2. As a control, ChIPs against
BAP111 showed that BAP binding to its targets SK1 and
KCNQ was unaffected by the knockdown of TTK69, MEP1,
or Mi2 (Fig. 6E).
In summary, our ChIP results showed that NuRD recruit-
ment required TTK69. In contrast, TTK69 binding was inde-
pendent of NuRD. Loss of Mi2 caused only a modest reduc-
tion of MEP1 recruitment, suggesting that TTK69 binding to
MEP1 suffices for promoter tethering. We conclude that, on
the loci examined, TTK69 binds first and then recruits NuRD
(Fig. 7).
DISCUSSION
Here we have studied the cooperation between the se-
quence-specific transcription factor TTK69 and the ATP-de-
pendent chromatin-remodeling factor NuRD. One prevalent
view of remodeler action is that remodelers act randomly to
open up chromatin, creating a window of opportunity for se-
quence-specific transcription factors to bind their cognate
DNA recognition sequences. A drawback of such a scenario is
that it does not readily explain the functional specialization of
remodelers and how they act in a gene-selective manner. In
this study, we provide an example of transcription factor bind-
ing preceding remodeler recruitment through selective pro-
tein-protein interactions. In addition, we provide a detailed
characterization of Drosophila NuRD.
FIG. 3. TTK69, MEP1, and Mi2 interact genetically. Concomitant
reduction of MEP1 and TTK69 or MEP1 and Mi2 causes an enhance-
ment of the rough-eye phenotype. Representative scanning electron
micrographs of adult eyes from flies with the indicated genotypes are
shown. The GMR driver was used to direct the expression of specific
interfering RNAs targeting TTK69 (B), Mi2 (C), or MEP1 (D), which
had only a slight effect on eye development and the arrangement of
ommatidia. However, a combined reduction in the levels of TTK69
and MEP1 (E) or Mi2 and MEP1 (F) strongly enhanced the rough-eye
phenotype.
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As part of our efforts to understand the molecular mecha-
nism underpinning transcription control by TTK69, we identi-
fied MEP1 as a TTK69-interacting protein. Subsequent pro-
teomic and biochemical analyses established MEP1 and
CDK2AP1/DOC1 as bona fide NuRD subunits. For example,
the sequence coverage and emPAI scores (identification scores
corrected for protein sequence length) of NuRD subunits in
our Mi2 and MEP1 purifications were remarkably comparable
(Table 1). Immunodepletion of CDK2AP1/DOC1 concomi-
tantly removes key NuRD subunits, including Mi2, MEP1, and
MTA1 (Fig. 2E), confirming that CDK2AP1/DOC1 is stably
associated with the majority of NuRD complexes in the extract.
Recently, the dMec complex, comprising solely MEP1 and
Mi2, was isolated from Kc cells (17). Thus, as seen more
commonly for chromatin-regulatory factors, MEP1 and Mi2
appear to be part of alternate assemblages. However, our re-
sults indicate that in embryo nuclear extracts, the majority of
Mi2 and MEP1 exists as part of NuRD.
In addition, our biochemical analysis confirmed the associ-
ation of MEP1 and TTK69. Genetic interaction assays pro-
vided independent functional evidence for cooperation be-
tween TTK69 and NuRD. TTK69 and NuRD colocalize on a
substantial fraction of their binding sites but also occupy
unique loci. Genomewide expression analysis revealed that the
transcriptomes of TTK69, MEP1, and Mi2 overlap signifi-
cantly. In contrast, the TTK69 gene expression profile corre-
lated poorly with remodelers other than NuRD, reflecting their
functional differentiation. Notably, some GO classes were
largely repressed by TTK69 and NuRD, whereas others were
mainly activated. Thus, it appears that some sets of functional
gene classes are coordinately regulated by TTK69 and NuRD.
Because both TTK69 and NuRD are commonly considered
transcriptional repressors, their apparently positive role might
be due to indirect effects. However, we note that a potential
positive role for HDACs has been raised as well (36). Likewise,
NuRD might directly activate certain target genes. Our ChIP
analysis established that TTK69 could bind its targets inde-
pendently of NuRD. Binding of NuRD, however, was criti-
cally dependent on TTK69. We conclude that TTK69 re-
cruits NuRD to selective loci, not the other way around (Fig.
7). Of course, interactions of NuRD itself with DNA and
histones are likely to contribute significantly to its targeting.
Transcription factors other than TTK69 will also mediate
NuRD recruitment to target loci. Conversely, there is no rea-
son to assume that NuRD is the only transcriptional cofactor
of TTK69.
Our work suggests that MEP1 is a genuine subunit of Dro-
sophila NuRD. What is the relationship between MEP1 and
NuRD in other organisms, including humans? Interestingly,
previous studies have shown that in C. elegans, MEP1 associ-
ates with the homologs of Mi2 (LET-418) and RPD3
(HDAC-1) and functions in the repression of germ line genes
in somatic cells (32). These observations are fully consistent
with the notion that worm MEP1 is part of NuRD. Because
FIG. 4. TTK69 colocalizes with MEP1 and Mi2 on many loci. (A to E) The distributions of TTK69 (red) and MEP1 (green) on Drosophila
salivary gland chromosomes were determined by immunostaining. (F to J) Likewise, the distributions of TTK69 (red) and Mi2 (green) were
determined. DNA stained blue (with DAPI) in the merged panels. The colocalization of TTK69 and NuRD on many sites is demonstrated by the
yellow staining in the merged panels and the similar patterns in split polytenes. However, TTK69 and NuRD also occupy unique loci.
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MEP1 is critical for Mi2 function in flies (this study) and
worms (32), we wondered whether there might also be a
human ortholog. Although straightforward database inspec-
tion did not reveal a mammalian homolog, a search using
the zinc finger domain of fly MEP1 revealed homology with
human ZFHX1B/SIP1/ZEB2. A direct Clustal 2.0 alignment
of ZFHX1B (35), Drosophila MEP1, and C. elegans MEP1
demonstrated a modest but suggestive homology between the
FIG. 5. Genomewide expression profiling reveals that TTK69, MEP1, and Mi2 control overlapping transcriptomes. (A) Selective depletion of
TTK69, MEP1, and Mi2. S2 cells were either mock treated or treated with dsRNA against TTK69, MEP1, or Mi2. Whole-cell extracts were
analyzed by Western immunoblotting using the indicated antibodies. ISWI and -tubulin served as loading controls. (B) The TTK69 transcriptome
correlates well with that of NuRD, but not with that of ISWI or (P)BAP. Agglomerative hierarchical cluster analysis of the expression profiles of
TTK69, NuRD, ISWI, and the (P)BAP core subunits SNR1, BRM, and MOR was performed. Clustering is based on Spearman R values. TTK69
and NuRD (green), ISWI (blue), and (P)BAP (red) clusters are indicated. (C) Principal-component (PC) analysis of gene expression profiles
reveals the close clustering of TTK69 with Mi2 and MEP1, but not with ISWI or the (P)BAP core subunits. (D) Venn diagram depicting the
numbers of genes that are coordinately regulated by TTK69, Mi2, and MEP1. Arrows indicate either upregulation or downregulation following
depletion. The numbers of genes affected are given. (E) GO analysis and biological pathway clustering of genes coordinately regulated by TTK69,
Mi2, and MEP1. morphogen., morphogenesis.
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3 proteins (see Fig. S1 in the supplemental material). Impor-
tantly, it was recently reported that ZFHX1B interacts physi-
cally and functionally with NuRD (35). Thus, not only does
ZFHX1B display structural similarity to MEP1; it also inter-
acts with NuRD, making it an extremely attractive candidate
mammalian ortholog. Additionally, ZFHX1B has been re-
ported to interact with the SMAD transcription factors, the
corepressor CtBP, and the acetyltransferase p300 (34). Sugges-
tively, we identified the Drosophila homologs of these three
proteins in our MEP1, but not Mi2, purifications (Table 1).
These observations provide additional support for the notion
that ZFHX1B and MEP1 might be orthologs; in addition, they
indicate that MEP1 might participate in additional interac-
tions, separate from NuRD.
Loss of heterozygosity of ZFHX1B/SIP1/ZEB2 has been
implicated in the etiology of Mowat-Wilson syndrome (MWS),
characterized by severe mental retardation and a range of
additional defects. Mice lacking ZFHX1B display defects in
early neurogenesis (33). Strikingly, a MWS-associated mutant
form of ZFHX1B is unable to bind and recruit NuRD (35). In
conclusion, we propose that MEP1 is an evolutionarily con-
served NuRD subunit that is critical for targeting. In this sense,
its function is reminiscent of that of selected signature subunits
within the SWI/SNF class BAP and PBAP remodelers (6, 23,
24, 26).
Mi2 and MEP1 were identified in a screen for SUMO-
dependent transcriptional repression (29). Both factors act
downstream of SUMOylation of the transcription factor Sp3.
MEP1 and Mi2 each interact with SUMO in vitro, and their
recruitment to an integrated reporter gene is dependent on the
SUMOylation of Sp3 (29). Extrapolating these observations
made for Sp3, it is an attractive idea that TTK69 SUMOylation
(20) will also modulate NuRD-dependent repression by TTK69.
Indeed, we also observed an interaction between SUMO and
Drosophila MEP1 and Mi2 (A. A. Travers and A. Bassett,
unpublished results). However, thus far, we were unable to
establish a direct function for SUMO in TTK69-directed si-
lencing. We note that previous studies revealed a critical role
for ubiquitylation/deubiquitylation of TTK in cell fate con-
trol (2, 21, 30). Likewise, it will be important to explore the
role of SUMO signaling in TTK69/NuRD repression during
development.
We identified the Drosophila homolog of the human CDK2-
interacting protein CDK2AP1/DOC1 as a NuRD subunit. This
small protein is a potential tumor suppressor (31), which thus
far has received little attention. However, its identification in
both mammalian (19) and fly NuRD strongly suggests that it is
a conserved subunit, which may play a regulatory role. In our
Mi2 and MEP1 purifications, we did not observe homologs of
any of the other proteins incidentally reported as NuRD sub-
units in other organisms. Thus, based on the results of others
and on this study, we surmise that the composition of NuRD as
depicted in Fig. 2F represents its conserved core.
In conclusion, we present here a biochemical characteriza-
FIG. 6. NuRD binding to selective promoters depends on TTK69, whereas TTK69 binding is independent of NuRD. (A) Upregulation of ARK,
Hairy, and En after TTK69, MEP1, or Mi2 knockdown. RNA was extracted and quantified by RT-qPCR using appropriate primers. mRNA levels
were normalized against those of CG11874, a gene whose expression did not change in our microarray experiments. Normalized mRNA levels were
expressed relative to those in mock-treated cells. Graphs represent the results of three independent biological replicate experiments. Error bars
represent the standard errors of the means. (B to E) ChIP-qPCR analysis of the binding of TTK69 (B), Mi2 (C), and MEP1 (D) to ARK, Hairy,
and En. The BAP target SK1 is not bound by TTK69 or NuRD and serves as a negative control. ChIPs were performed on chromatin from
mock-treated or RNAi-depleted cells for TTK69, MEP1, or Mi2. (E) The binding of BAP111 to its targets SK1 and KCNQ is not affected by RNAi
against TTK69, MEP1, or Mi2. Cross-linked chromatin was prepared from mock-treated or RNAi-treated cells. All ChIP data are the results of
at least 3 independent biological replicates. Error bars represent the standard errors of the means.
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tion of Drosophila NuRD. Our results showed that MEP1 and
CDK2AP1 are two novel NuRD subunits. MEP1 plays a key
role in linking NuRD to TTK69. Genomewide analysis of tran-
scription revealed that TTK69 is critically required for a sig-
nificant portion of NuRD-regulated genes. However, we note
that TTK69 and NuRD also regulate genes independently of
each other. Our results support a model in which TTK69 re-
cruits NuRD to selective loci, rather than one in which NuRD-
mediated chromatin remodeling is required for DNA binding
by TTK69. We suggest that TTK69 belongs to a group of
transcription factors, sometimes referred to as pioneer pro-
teins, that bind chromatin independently of remodelers (41).
We propose that, rather than acting in a generic fashion, spe-
cific remodelers cooperate with selective transcription factors
in the control of gene expression.
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Abstract
DOC1 (deleted in oral cancer 1) is a potential tumor suppressor that is either deleted or 
down regulated in several cancers including oral cancer. DOC1 has been proposed 
as a tumor suppressor in light of its role in inhibition of Cyclin dependent kinase 
2 (CDK2) function and cell cycle regulation. We earlier reported DOC1 as a subunit 
of the Nucleosome Remodeling and Deacetylase (NuRD) complex in Drosophila 
(Chapter 3). The precise mechanism of tumor suppression by DOC1 in the context 
of the NuRD complex remains enigmatic. Re-expression of DOC1 in deleted oral 
cancer cell lines resulted in cell growth inhibition. Proteomics analysis identified 
SMAD4, a transducer of transforming growth factor-beta (TGF-b) signalling as a 
DOC1 interacting protein. RNAi-mediated knockdown of DOC1 and Chromatin-
helicase-DNA-binding-protein-4 (CHD4) (ATPase subunit of NuRD) resulted in de-
repression of SMAD4 target genes involved in tumorigenesis. Our results suggest 
that DOC1-NuRD complex functions as a repressor of TGF-b regulated genes, which 
are involved in promoting cell proliferation, metastasis and angiogenesis.
Introduction
DOC1 is a highly conserved, ubiquitously expressed gene located on chromosome 
12q24. It encodes 115-aa nuclear polypeptide that is down regulated or deleted 
in ~70% of oral cancers (Wong et al., 2012). DOC1 was originally identified as 
a novel tumor suppressor using chemically-induced oral cancer in hamster. 
Reintroduction of DOC1 into the malignant hamster oral keratinocytes and in vivo 
mouse models of head and neck cancer resulted in the tumor growth inhibition, 
suggesting reversal of malignant transformation (Figueiredo et al., 2005; Wong 
et al., 1996). DOC1, also called CDK2AP1 (CDK2-associated protein 1), is a CDK2 
inhibitor implicated in cell cycle regulation through G1/S transition (Shintani et 
al., 2000). DOC1 inhibits CDK2-mediated phosphorylation of DNA-polymerase a/
primase that resulting in inhibition of DNA synthesis and cell growth (Matsuo et al., 
2000). Therefore, execution of tumor suppressive activity by DOC1 is thought to be 
through regulation of the cell cycle (Shintani et al., 2000; Wong et al., 2012). Targeted 
deletion of DOC1 in mice resulted in embryonic lethality (Kim et al., 2009b). DOC1 
is also implicated in embryonic stem cell differentiation through the control of RB 
phosphorylation and epigenetic regulation of OCT4 expression (Deshpande et al., 
2009; Kim et al., 2009a). DOC1 has also been identified as a subunit of the NuRD 
chromatin remodeling complex in Drosophila (Chapter 3) and also in human cells 
(Le Guezennec et al., 2006; Spruijt et al., 2010). 
TGF-b family members play an important role in cell growth, differentiation 
and apoptosis. SMAD proteins, a family of eight members (SMAD1-8) are the 
intracellular mediators of canonical TGF-b family signalling (ten Dijke and Hill, 
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2004). SMAD4 is a central mediator of transcriptional responses to TGF-b-induced 
transcriptional responses (Hahn et al., 1996; Lagna et al., 1996). SMAD4 is the key 
factor in the TGF-b pathway and can function as a tumor suppressor. Germline 
mutations in the SMAD4 cause Juvenile Polyposis Syndrome (JPS) with high risk 
of developing colorectal cancer. Homozygous deletion or somatic mutation of 
SMAD4 gene occurs most frequently in pancreatic, gastrointestinal, and skin 
cancers (Waite and Eng, 2003). Conditional knockout of SMAD4 gene in mouse 
skin resulted in the development of squamous cell carcinoma (Qiao et al., 2006). 
Mouse models with tissue specific deletion of SMAD4 gene revealed that the loss 
of SMAD4 accelerates tumor formation (Yang and Yang, 2010). Mutations or loss 
of heterozygosity of other TGF-b core components were also observed in several 
human cancers (Levy and Hill, 2006). TGF-b acts as a tumor suppressor through 
the regulation of cell cycle and apoptosis by inhibiting the expression of the MYC 
oncogene and activating the expression of cell cycle inhibitors, such as p21 and 
p15. In contrast, TGF-b also actively participates in tumor development through 
the initiation of processes such as tumor cell invasion, epithelial-to-mesenchymal 
transition (EMT) and metastasis (Meulmeester and Ten Dijke, 2011). Thus, at the 
early stages of tumor development TGF-b acts as a tumor suppressor and later 
stages it may actively promote tumorigenesis. 
Since DOC1 is a potential tumor suppressor having implications in human 
cancers, we shifted our focus from Drosophila DOC1 to human DOC1. Here we 
investigate in detail the gene regulation by human DOC1. We propose a novel 
function for DOC1 in gene regulation through its interaction with SMAD4.
Results
DOC1 inhibits the cell growth in squamous cell carcinoma cell lines  
DOC1 is a potential growth suppressor which is found deleted in many cancers 
including oral cancer. Therefore, we tested the effect of re-expression of DOC1 
in deleted squamous carcinoma cell lines SCC4 and SCC9. Expression of DOC1 is 
analyzed by Western blotting analysis (Figure 1A). Reintroduction of DOC1 in both 
SCC4 and SCC9 cells resulted in inhibition of cell proliferation in a time-dependent 
manner compared to the cells expressing a control plasmid (Figure 1B). Hence, 
DOC1 acts as a suppressor of growth in these cancer cell lines. These results are 
in agreement with earlier reports that DOC1 elicits cytostatic effects through the 
regulation of cell cycle by inhibition of CDK2 (Matsuo et al., 2000; Shintani et al., 
2000). However, the role of DOC1 as a tumor suppressor, being a part of NuRD 
complex still remains enigmatic. Therefore, we took an unbiased proteomic 
approach to unravel the gene regulatory networks of the DOC1-NuRD complex.
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Figure 1; Re-expression of DOC1 inhibits 
cell growth in SCC4 and SCC9 cells: 
SCC4 or SCC9 cells were transiently 
transfected with either control plasmid 
(Ctl) or plasmid expressing DOC1. 
Expression of DOC1 is analysed by 
Western blotting analysis Tubulin serves 
as a loading control (A).  Cells were 
counted by using heamocytometer at 
36, 72 and 96 hours of post-transfection. 
The average number of cells from three 
independent experiments is plotted 
against the time as indicated (B).
DOC1 interacts with the TGF-ß intracellular mediator SMAD4
We took a proteomics approach to make an inventory of DOC1 associated 
proteins in HeLa nuclear extracts. Nuclear extracts were incubated with protein 
A-Sepharose beads coated with affinity-purified antibodies directed against DOC1. 
Following extensive washes, bound and unbound material was resolved by SDS-
PAGE followed by coomassie staining (Figure 2A). Massspectrometric analysis 
revealed that DOC1 is tightly associated with the NuRD complex and with SMAD4 
a key intracellular mediator of TGF-b signalling (Figure 2A and Table 1). No binding 
of NuRD complex or SMAD4 is observed to the control beads coated with anti-
glutathione-S-transferase (GST) antibodies. We found all known subunits of the 
NuRD complex in DOC1 immunopurifications (IPs) including chromodomain 
helicases CHD3 and CHD4 histone deacetylases HDAC1, HDAC2 and HDAC3, 
metastasis tumor antigens MTA1, MTA2 and MTA3, histone binding proteins RBBP4 
and RBBP7, GATA-like transcription factors, GATAD2A/2B and methyl-DNA binding 
proteins MBD2 and MBD3. These results are comparable with the Drosophila DOC1 
IPs carried out on embryo nuclear extracts (Table S1). These findings suggest that 
DOC1 is an evolutionally conserved subunit of the NuRD complex. In addition, we 
also found CHD5 (chromodomain helicase 5), a paralouge of Mi2/CHD4 as a subunit 
of the NuRD complex. 
In parallel, we used affinity-purified antibodies directed against CHD4 
to purify NuRD complex. Massspectrometric analysis revealed the presence of 
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DOC1 and all core NuRD subunits (Figure 2B and Table 1). These results suggest the 
NuRD complex comprises: CHD3/4/5, HDAC1/2/3, MTA1/2/3, RBBP4/7, GATA2A/2B, 
MBD2/3 and DOC1. We previously reported MEP1 as a subunit of Drosophila NuRD 
complex. MEP1 targets the NuRD complex to different genomic loci by binding to 
the BTB-POZ domain transcription factor Tramtrack 69 (TTK69) (Chapter 3). However, 
there are no homologues of MEP1 or TTK69 identified so far in vertebrates. MEP1 
is a zinc finger and homeobox domains containing protein. Incidentally we found 
a similar zinc finger protein, zinc finger and homeobox 3 (ZFXH3) in CHD4 IPs. 
Therefore, ZFHX3 could be a functional homologue of MEP1 in humans. Similarly 
we also found ZBTB2 (zinc finger and BTB-POZ domain 2) in both DOC1 and CHD4 
IPs. This could be the functional homologue of TTK69 (Supplementary Table 1). 
Additionally we also found LSD1/KDM1A in both DOC1 and CHD4 IPs. LSD1 is a 
subunit of NuRD complex (Wang et al., 2009). However, we do not find LSD1 in 
Drosophila NuRD IPs (Chapter 3 and Table S1). We also found CDK2, a known 
interactor of DOC1 in both DOC1 and CHD4 IPs. To our surprise, we did not find 
SMAD4 in CHD4 IP’s which we had found in DOC1 IP’s (Figure 2A, 2B, 2C, Table 1). 
These findings suggest that SMAD4 is not a subunit of NuRD complex but interacts 
with the NuRD through the DOC1 subunit.
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Figure 2; Immunopurifica-
tion of DOC1 and CHD4: 
Immunopurification of DOC1 
(A) and CHD4 (B) from HeLa 
nuclear extracts. HeLa nucle-
ar extracts were incubated 
with Protein A-Sepharose 
beads coated with either 
control (a-GST) antibodies 
(mock) or affinity-purified 
a-DOC1 or a-CHD4 antibod-
ies. Input, unbound material 
and proteins retained on the 
beads after extensive wash-
ing were resolved by SDS-
PAGE and visualized by Coo-
massie staining. Bands were 
excised and proteins were 
identified by nanoflow LC-
MS/MS mass spectrometry. 
The various mass spectrom-
etry scores of the indicated 
proteins are listed in Table 1. 
C) Cartoon summarizing our 
proteomic results. The core NuRD complex comprises: the ATPase’s CHD3/4/5, HDAC1/2/3, 
MTA1/2/3, RBBP4/7, GATA2A/2B, LSD1 (KDM1A), MBD2/3 and DOC1. SMAD4 interact with 
NuRD through DOC1 subunit.  ZBTB and ZFHX3 are NuRD interacting proteins.
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DOC1 is a repressor of SMAD4 target genes
Next we asked whether DOC1-NuRD cooperates with SMAD4 to regulate the TGF-b 
responsive gene expression. To test this, we performed RNAi-mediated knockdown 
of DOC1 and CHD4 followed by RT-qPCR analysis of SMAD4 target genes in TGF-b 
responsive HaCaT cells. The knockdown efficiency is analyzed by RT-qPCR (Figure 
2A). Knockdown of DOC1 and CHD4 resulted in the up-regulation of SMAD4 target 
genes, such as MMP9, SNAIL and EpCAM. Similarly, up-regulation of these target 
genes was observed upon stimulation by TGF-b (Figure 2B, 2C & 2D). MMP9 is a 
matrix metalloproteinase which promotes breast cancer invasion in a SMAD4- and 
TGF-b- dependent manner (Wiercinska et al., 2011). SNAIL is a TGF-b inducible gene 
implicated in EMT and tumor invasion (Xu et al., 2009). EpCAM promotes metastasis 
by inhibiting the expression of E-cadherin, a cell-cell adhesion molecule (van der 
Gun et al., 2010). Surprisingly, the expression of other SMAD4 target genes, such 
as p21 and p15 were not affected by DOC1 or CHD4 knockdowns (Figure 2E & 2F). 
These results suggest that the DOC1-NuRD complex regulates the expression of 
specific set of TGF-b responsive genes that promote tumor development. Whether 
the DOC1-NuRD complex directly controls the expression of these genes still needs 
to be addressed.
MW
kDa MS
CHD4
ES
Protein
identity Comments
CHD3
ZFHX3
MTA1
GATAD2A
HDAC1
RBBP4
DOC1
MBD2
MBD3
ZBTB2
233
218
223
RBBP7
HDAC2
KDM1A
GATAD2B
MTA2
MTA3
CHD4
CHD5
404
79
75
66
68
66
55
55
47
47
43
32
92
12
51
7603 21.72
1457 0.68
1688 0.83
1826 0.34
2419 8.42
2970 16.36
1747 7.67
2496 15.78
2025 12.07
1738
1823
64.16
129.9
1385
1474
5.63
12.21
1499
1314
10.73
21.9
1003 0.99
281 4.24
393 0.59
Chromodomain-helicase-DNA-binding protein 4 (Mi-2ß)
Chromodomain-helicase-DNA-binding protein 4 (Mi-2α)
Chromodomain-helicase-DNA-binding protein 4 (Mi-2 related)
Metastasis-associated protein 1
Metastasis-associated protein 2
Metastasis-associated protein 3
Transcriptional repressor p66-alpha
Transcriptional repressor p66-beta
Histone deacertrylase 1
Histone deacertrylase 2
Histone-binding protein RBBP4
Histone-binding protein RBBP7
Methyl-CpG-binding domain protein 2
Methyl-CpG-binding domain protein 2
Lysine-specific histone demethylase 1 A
Deleted in Oral Cancer 1
Zinc finger homeobox protein 3, drosophila MEP1
Zinc finger and BTB domain-containing protein 2, Tramtrack69
MS ES
DOC1
4661 4.06
8132 40.57
1992 1.1
2898 13.28
3153 20.7
2001 7.21
2642
2154
14.25
17.72
1953
2028
92.67
146.6
1491
1668
6.63
15.29
1366
1575
9.05
68.57
808 0.66
378 9.16
303 0.42
SMAD4 48 622 1.81
CDKN2 30 215 0.63 88 0.28 Cyclin dependent kinase 2
SMAD transcription factor, TGF-ß signalling
MS - Mascot score ES - emPAI score
Table1; Massspecrtometric analysis of DOC1 and CHD4 immunopurifications
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Discussion
Here we explore the physical and functional relationship between chromatin 
remodeler NuRD and TGF-b signalling. TGF-b plays a dual role in tumorigenesis. 
In the initial stages of cancer development, TGF-b acts as a tumor suppressor by 
inhibiting the cell growth and accelerating apoptosis. However, at later stages, 
TGF-b promotes tumor growth by facilitating migration, invasion and angiogenesis 
(Elliott and Blobe, 2005). Our results suggest that DOC1-NuRD inhibits the 
expression of TGF-b-induced genes, such as MMP9, SNAIL and EpCAM which 
promote tumor invasion, EMT and metastasis. Our findings are in agreement with 
Zolochevska et al., who showed that reintroduction of DOC1 in deleted cancer 
cell lines resulted in inhibition of tumor invasion, metastasis and angiogenesis 
(Zolochevska and Figueiredo, 2010). However, the molecular mechanism of 
inhibition of tumorigenesis by DOC1 is not clear. It is possible that SMAD4 binds 
to DOC1 to recruit the NuRD complex for establishing transcriptional repression of 
TGF-b responsive genes involved in tumorigenesis. Further research is warranted 
to address these issues.
DOC1 is a growth inhibitor that executes its function by inhibiting the cell 
cycle through the regulation of CDK2 (Matsuo et al., 2000; Shintani et al., 2000). 
Therefore, deletion or down regulation of DOC1 is found in many cancers including 
oral cancer (Wong et al., 2012). Apart from cell cycle regulation, DOC1 is also tightly 
associated with the NuRD complex in Drosophila and in mammalian cells. What 
could be the relevance of the association of DOC1 with NuRD complex in functioning 
as a tumor suppressor? Our findings suggest that the DOC1-NuRD complex inhibits 
the expression of TGF-b responsive genes involved in tumorigenesis. Thus, DOC1 
might execute its tumor suppressor activity by multiple mechanisms, such as 
inhibition of cell cycle and inhibition of the tumorigenesis activities of TGF-b. 
Experimental procedures
Antibody production, Immunopurification and massspectrometry analysis: 
Polyclonal antibodies were generated by immunizing the rabbits or guinea pigs 
with GST-tagged proteins expressed in E. coli and affinity purified as described 
previously (Chalkley and Verrijzer, 2004). DOC1; Full-length protein and CHD4: 
N-terminus, 1 to 419 aa (amino acids). Immunopurification was essentially carried 
out by using standard procedures as described earlier (Chalkley and Verrijzer, 2004). 
Briefly, HeLa nuclear extracts were incubated with Protein A-Sepharose beads 
cross-linked with either anti-GST (mock) or anti-DOC1 or anti-CHD4 antibodies. 
Following the affinity purification beads were subsequently washed with HEMG 
buffer (25mM HEPES-KOH pH 7.6, 0.1mM EDTA, 12.5mM MgCl
2
, 10% glycerol, 0.1% NP-
40 and a cocktail of protease inhibitors) containing 300 mM KCl. Input, unbound and 
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Figure 3; DOC1 represses the SMAD4 target genes: HaCaT cells were transduced with 
lentivirus encoding either non-targeted shRNA (Mock-KD) or shRNA against DOC1 or 
CHD4. Cells were either untreated (UNT) or treated with 5 ng/ml of TGF-b for 24 hours. 
cDNA prepared from the total RNA was used for the expression analysis of indicated genes 
by RT-qPCR. Error bars indicate the standard deviation derived from three independent 
experiments. Knockdown efficiency is accessed by RT-qPCR analysis of DOC1 and CHD4 (A). 
The expression of following TGF-b target genes were analyzed, MMP9 (B), EpCAM (C), SNAIL 
(D), p21 (E) and p15 (F).
immunoprecipitated protein samples were resolved by SDS-PAGE and proteins 
were identified by nanoflow liquid chromatography-tandem massspectrometry. 
Cell growth assay: SCC4 or SCC9 cells were seeded into 6 well plates. Followed 
by cells were transfected with either control plasmid or plasmid expressing DOC1. 
Cells were counted at 36, 72 and 96 hours post-transfection using heamocytometer. 
Cell culture and lentiviral procedures: Cell culture was essentially carried out 
according to the standard procedures. Lentivirus expressing specific shRNA 
were obtained form shRNA library (Erasmus Centre for Biomics, Erasmus University 
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Medical Centre, Rotterdam, The Netherlands). High-titer viral stocks were produced 
in HEK293T cells by cotransfection of shRNA vector with viral packaging constructs 
using standard transfection procedures. HaCaT cells were then transduced with 
lentivirus expressing specific shRNA against DOC1 and CHD4 (see supplementary 
for shRNA sequences). Knockdowns were carried out for 4 days. 
Cloning and transfection procedures: For transient expression in mammalian 
cells full-length DOC1 cDNA was cloned into pQCXIP vector with Flag-tag sequence 
or HA-tag sequence flanking at the 5’ end. Transient transfections were carried 
out using Fu-Gene transfection reagent (Roche diagnostics) and procedures were 
followed essentially according to the manufacturer’s instructructions. Transfections 
were carried out for 48 hours and cell lysates were made in SDS-PAGE loading 
buffer and further analyzed by SDS-PAGE and immunobloting. 
Real time quantitative PCR: RNA isolation, RT-qPCR, microarray experiments and 
data analysis were performed using standard procedures. Details of primers are 
given in the supplementary section.
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Supplementary information:
Primers used for q-PCR:
SNAIL: ACCACTATGCCGCGCTCTT & GGTCGTAGGGCTGCTGGAA
MMP9: TACTGTGCCTTTGAGTCCG & TTGTCGGCGATAAGGAAG
EpCAM: GGACTAGTATGGCGCCCCCGCAGG & CCTGATCATTATGCATTGAGTTCCC
ARP: CACCATTGAAATCCTGAGTGATGT & TGACCAGCCGAAAGGAGAAG
p15: ATGCGCGAGGAGAACAAG & CTAGGTTCCAGCCCCGAT
p21: TGTGGACCTGTCACTGTCTTG & CGGCGTTTGGAGTGGTAGAA
DOC1: CTTACAAACCGAACTTGGC & GTTGCTGGGTGTAGCCTAG
CHD4: CGCAAGAAACTCCGAACCACT & GCACACCTCGCAATAGTCCT
shRNA sequences: 
DOC1:
CATGGCAACGTCTTCACAGTA
CTTGGCAGAAACGGAACGGAA
CGCGGCATCATTCACGCTAGA
GAAGGAGATCAGACCCACGTA
CCAAAGCAAATACGCGGAGCT
MW
kDa
Protein
identity Comments
MW
kDa
Protein
identity
dMi2 
MEP1 
MTA1-like 
RPD3 
p55 CAF1 
DOC1
MBD-like A 
MBD-like B 
TTK69 
p66/68-like 
CHD3
ZFHX3
MTA1
GATAD2A
HDAC1
RBBP4
DOC1
MBD2
MBD3
ZBTB2
233
218
223
RBBP7
HDAC2
KDM1A
GATAD2B
MTA2
MTA3
CHD4
CHD5
404
79
75
66
68
66
55
55
47
47
43
32
92
12
51
Chromodomain-helicase-DNA-binding protein 4 (Mi-2ß)
Chromodomain-helicase-DNA-binding protein 4 (Mi-2α)
Chromodomain-helicase-DNA-binding protein 4 (Mi-2 related)
Metastasis-associated protein 1
Metastasis-associated protein 2
Metastasis-associated protein 3
Transcriptional repressor p66-alpha
Transcriptional repressor p66-beta
Histone deacertrylase 1
Histone deacertrylase 2
Histone-binding protein RBBP4
Histone-binding protein RBBP7
Methyl-CpG-binding domain protein 2
Methyl-CpG-binding domain protein 2
Lysine-specific histone demethylase 1 A
Deleted in Oral Cancer 1
Zinc finger homeobox protein 3, drosophila MEP1
Zinc finger and BTB domain-containing protein 2, Tramtrack69
225
97
175
95
58
48
36
25
29
69
MS ES
hDOC1 dDOC1
MS ES
4661 4.06
8132 40.57
1992 1.1
2898 13.28
3153 20.7
2001 7.21
2642
2154
14.25
17.72
1953
2028
92.67
146.6
1491
1668
6.63
15.29
1366
1575
9.05
68.57
808 0.66
378 9.16
303 0.42
SMAD4 48 622 1.81
8658 17.12
4034 16.78
3725 7.1
2297 2.72
1993 12.62
1375 4.84
1168 16.56
667 10.81
615 3.05
1421 2.06
CDKN2 30 215 0.63 91 0,19 Cyclin dependent kinase 2
SMAD transcription factor, TGF-ß signalling
CDC2c
hDOC1- human DOC1, dDOC1- drosophila DOC1 MS - Mascot score, EM - emPAI score
36
Table S1; Comparison of massspecrtometric analysis of hDOC1 and dDOC1 
immunopurifications
CHD4:
CCTTACTAGAATTGGTGTTAT
CGAAGGTTTAAGCTCTTAGAA
GCTGCTGACATCCTATGAATT
GCTGACACAGTTATTATCTAT
GCGGGAGTTCAGTACCAATAA
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Genetics and epigenetics play a crucial role in the normal growth and development 
of an organism. Alteration of the key cell growth regulatory pathways is the 
major cause of developmental disorders and diseases including cancer (Hanahan 
and Weinberg, 2011). Among these, misregulation of transcription and cell 
cycle regulatory proteins are the major determining factors. Thus, unravelling 
transcription and cell cycle regulatory pathways is crucial to identify the therapeutic 
targets. This thesis has studied the gene regulatory pathways of a metabolic enzyme 
GMPS and the chromatin remodeler NuRD and their involvement in development 
and disease.
Chapter 2 describes the metabolic enzyme GMPS as a positive regulator of the 
p53 stability and function upon cellular stress. Several indirect mechanisms 
were proposed for p53 activation upon stress; p53 is phosphorylated by ATM/
ATR kinases resulting in its dissociation from MDM2 and similarly, ATM/ATR-
mediated phosphorylation of MDM2 leads to its disassociation from USP7, 
thus resulting in MDM2 autoubiquitylation and degradation. It has also been 
proposed that dephosphorylation of USP7 by ATM activated phosphatase PPM1G 
results in the disruption of USP7 and MDM2 interaction that eventually leads to 
MDM2 destabilization and p53 activation (Khoronenkova et al., 2012). However, 
stabilization of p53 directly by deubiquitylation upon stress is still an unresolved 
issue. Our findings suggest that upon stress GMPS translocates into the nucleus and 
forms a stable complex with USP7 and p53. GMPS binds to USP7 at the C-terminal 
Ubiquitin like-domain (Ubl) where as p53 binds to USP7 at the N-terminal TRAF-
like domain. Ubl domains are critical for USP7 catalytic activity. GMPS binds to Ubl 
domain and allosterically hyperactivates USP7 deubiquitilase activity (Faesen et al., 
2011; Sheng et al., 2006). Thus, GMPS might act as a bridging factor between p53 
and USP7 resulting in p53 stabilization by deubiquitylation. GMPS/USP7 complex 
is also implicated in transcriptional repression by deubiquitylation of histone H2B. 
p53 mediates the cellular stress response by transcriptional activation or repression 
of genes. RNAi-mediated depletion of GMPS/USP7 results in de-repression of p53 
repressed genes. Therefore, it is the interesting topic for future study to address 
whether p53 recruits the GMPS/USP7 complex to promoters of its target genes for 
establishing transcription repression. 
GMPS plays a dynamic role in the regulation of error-free cell division. 
GMPS resides in the cytoplasm and synthesizes nucleotides to support cell growth. 
However, upon cellular stress GMPS acts as a first responder to the stress and 
translocates to the nucleus to stabilize p53. GMPS acts as a sensor of the nucleotide 
pool in the cell and responds to replicative stress caused by the depletion of 
nucleotides. Replicative stress and the resulting genomic instability has been 
proposed to be the key driving force in early stages of cancer development. 
Oncogenic signals triggering cell proliferation without concomitant elevation in 
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nucleotide synthesis results in replicative stress which eventually leads to DNA 
damage and carcinogenesis (Bester et al., 2011). Therefore, GMPS might play a 
crucial role to maintain cellular homeostasis by coordinating cell division with 
nucleotide synthesis. Thus, GMPS act as guardian of the cell cycle to safeguard 
normal proliferation of the cells.
Ubiquitylation and deubiquitylation of GMPS is catalysed by TRIM21 and 
USP7 respectively. GMPS exists as two isoforms in the cells; monoubiquitinated 
form resides in the cytoplasm and unmodified form in the nucleus. Then, what 
is the relevance of monoubiquitylation of GMPS to its cytoplasmic function? 
Posttranslational modification of metabolic enzymes has been shown to 
influence their catalytic activity, oligomerization and subcellular localization. 
Phosphorylation and acetylation have been shown to have antagonistic effects 
on the catalytic activity of Phosphoenolpyruvate carboxylase (PEPC), an enzyme 
that functions in plant C4-metabolism. Interestingly, monoubiquitylation of PEPC 
has been shown to activate its catalytic function by sensitizing the enzyme to its 
allosteric activators (O’Leary et al., 2011; Uhrig et al., 2008). It is interesting to note 
that monoubiquitylation of GMPS takes place in the glutamine amidotransferase, 
ATP hydrolysis, and C-terminal dimerization domain (Chapter 2, Figure 6). Therefore, 
monoubiquitylation might play a crucial role in activating GMPS nucleotide 
biosynthetic function. GMPS is deubiquitinated by USP7 in the nucleus. The 
relevance of deubiquitylation of GMPS is unclear at this moment. It is possible 
that deubiquitylation of GMPS is essential for binding and activation of USP7 
deubiquitilase activity. Clearly, additional research is warranted to investigate the 
influence of monoubiquitylation on GMPS functions.
TRIM21 binds to GMPS in unstressed cells. This retains GMPS in the 
cytoplasm. Upon stress GMPS dissociates from TRIM21 resulting in GMPS 
nuclear translocation. The cause for the dissociation of GMPS and TRIM21 is 
not clear at this moment. It is possible stress response kinases such as ATM/ATR 
or check point kinases phosphorylate either TRIM21 or GMPS leading to their 
disassociation. However, in depth studies are required to address these issues. 
GMPS is a positive regulator of the tumor suppressor p53. Therefore, GMPS could 
also be acting as tumor suppressor by regulating p53. However, elevated levels of 
nucleotide biosynthetic enzymes, including GMPS have been reported in several 
cancers (Weber, 1983). GMPS is also reported as a poor prognostic marker for 
patient survival in breast cancers (van ‘t Veer et al., 2002). How can this paradox 
be explained? Our findings suggest that GMPS nuclear localization is crucial for 
p53 regulation. Monoubiquitylation of GMPS catalysed by TRIM21 results in its 
cytoplasmic retention that prevents p53 stabilization. TRIM21 is also found to 
be over-expressed in several cancers including colorectal, breast, ovarian, lung 
and cervical cancers (http://www.proteinatlas.org/ENSG00000132109/cancer). 
Therefore, TRIM21 might play a crucial role in carcinogenesis by targeting GMPS 
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to the cytoplasm and forcing it to synthesize nucleotides to fuel cancer cell growth 
and at the same time preventing GMPS-mediated stabilization of the tumor 
suppressor p53.  However, in detail investigation has to be carried out in future to 
address the role of TRIM21 in cancer development. 
Chapter 3 describes the purification and functional characterization of the Drosophila 
NuRD complex. Through a proteomics approach we identified Drosophila MEP1 
(CG1244) and DOC1 (CG18292) as bona fide subunits of the NuRD complex. MEP1 
is a Kruppel-type-zinc finger protein with putative SUMO-interacting motif. MEP1 
form a NuRD-like complex in C. elegans by interacting with LET-418 (Mi2) and 
HAD-1 (HDAC1) to repress the expression of germline specific genes in somatic 
cells during embryogenesis (Unhavaithaya et al., 2002). In this study, we found a 
similar complex in Drosophila comprising of MEP1, Mi2, RPD3 (HDAC1) and other 
subunits of NuRD. MEP1 mediates transcriptional repression of neuronal specific 
genes by TTK69 through recruitment of the NuRD complex. TTK69 is an important 
transcription factor which plays a crucial role in neuronal cell fate decision and 
eye development in Drosophila. Thus, role of MEP1 in transcription regulation and 
developmental processes appears to be conserved in C. elegans and Drosophila. 
In contrast to our findings, a two-subunit complex comprising MEP1 
and Mi2 called dMec, was isolated from Drosophila KC cells. dMec is functionally 
different from classical Mi2-NuRD complex (Kunert et al., 2009). Thus, multiple MEP1 
containing complexes appear to exist in Drosophila. Therefore, it is the future area 
of interest to investigate specific roles of different MEP1 complexes in Drosophila 
development. MEP1 is also implicated in SUMO-dependent transcriptional 
repression. MEP1 binds to sumoylated Sp3 through its SUMO-interacting motif 
and recruits Mi2 for Sp3-dependent transcriptional repression of target genes 
(Stielow et al., 2008). Thus, MEP1 participate in transcription regulation by multiple 
mechanisms. 
Additionally, we also identified DOC1 as a bona fide subunit of the 
Drosophila NuRD complex. DOC1, also called as CDK2AP1, is found deleted in 
several cancers including oral cancer. DOC1 is also reported as a subunit of human 
NuRD complex (Le Guezennec et al., 2006; Spruijt et al., 2010). Thus, DOC1 is an 
evolutionally conserved subunit of the NuRD complex. Therefore, it is interesting 
to investigate the role of Drosophila DOC1 in gene regulation. 
In this study, we investigated the mechanism of TTK69-mediated 
transcription regulation in detail. TTK69 is a transcriptional repressor implicated in 
the neuronal cell fate determination (Okabe et al., 2001), eye development (Li et al., 
1997; Xiong and Montell, 1993) and regulation of mitosis (Baonza et al., 2002). TTK69 
is tightly regulated at the protein level by ubiquitin-mediated degradation. UBP64 
has been shown to stabilize TTK69 by deubiquitylation, which is an important 
pathway in Drosophila eye development (Bajpe et al., 2008). Our findings suggest 
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that TTK69 and the NuRD complex work together in gene regulation. Therefore, it 
is interesting to address in future whether the NuRD complex also participates in a 
wide range of developmental processes regulated by TTK69. 
PP
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SMAD4
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Figure 1; Overview of TGF-ß signalling: TGF-b is a cell surface receptor with serine/
threonine kinase activity. TGF-b superfamily consists of more than 40 structurally related 
proteins. They can be subdivided into several groups, including TGF- b, bone morphogenic 
proteins (BMP) and activins/inhibins. Functionally, SMADs are classified into three groups, 
receptor-associated SMADs (R-SMADs: SMAD1, SMAD2, SMAD3, SMAD5), which are 
phosphorylated by receptor kinases, common mediator SMAD (Co-SMAD: SMAD4) and 
inhibitory SMADs (I-SMADs: SMAD6, SMAD7). SMAD4 in association with SMAD2 and SMAD3 
mediates TGF-b  signalling and together with SMAD1 and SMAD5 mediates BMP signalling. 
SMAD7 inhibits phosphorylation of R-SMADs, whereas, SMAD6 disrupts SMAD1 and SMAD4 
interaction. 
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Chapter 4 describes gene regulatory network of human DOC1. Here we explore the 
precise role of DOC1 as a tumor suppressor through its association with the NuRD 
complex. We found SMAD4 as a DOC1 interacting protein. SMAD4 is a common 
intracellular mediator of TGF-b- and BMP-signalling (ten Dijke and Hill, 2004), see 
Figure 1. Our findings suggest that SMAD4 and the DOC1-NuRD complex works 
together in the transcriptional repression of TGF-b target genes, which are involved 
in the tumorigenesis. The systemic deletion of SMAD4 in mouse skin results in the 
development of squamous cell carcinoma (Qiao et al., 2006). Deletion of DOC1 
also results in the development of squamous cell carcinoma. Therefore, DOC1 and 
SMAD4 function as tumor suppressors of squamous cell carcinoma. However, the 
in vivo relevance of interaction between DOC1 and SMAD4 in tumor suppression 
needs to be addressed. 
 Our proteomics analysis identified ZFHX3 and ZBTB2 as NuRD interacting 
proteins. ZFHX3 and ZBTB2 have similar domains as Drosophila MEP1 and 
TTK69 respectively. ZFHX3 is an AT-rich DNA binding protein and implicated in 
transcriptional repression (Morinaga et al., 1991). ZBTB2 is a BTB-POZ domain 
containing transcription factor (Jeon et al., 2009). We established functional 
cooperation between TTK69, MEP1 and NuRD complex in transcription regulation 
in Drosophila (Chapter3). Therefore, it is an interesting topic for future investigation 
to address whether similar functional cooperation exists between ZBTB2, ZFHX3 
and NuRD complex in transcription regulation and developmental processes in 
humans. 
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Summary
Controlled expression of genes is essential for normal growth and development 
of an organism. Alteration in gene expression by either mistargeting, deletion or 
degradation of important transcription factors or chromatin regulators can lead 
to changes in cellular physiology which ultimately can cause developmental 
disorders and diseases. Therefore, understanding the underlying mechanisms of 
gene regulation is crucial for identifying therapeutic targets.
Chapter 2 describes the role of metabolic enzyme GMPS in regulation 
of p53 stability and function. Stabilization of p53 is essential to carry out cellular 
adaptation to stress. In response to diverse cellular stresses p53 gets stabilized and 
regulates the expression of genes that control cell cycle, apoptosis, senescence 
and cell metabolism. Thus, cells gain a significant growth advantage in the absence 
of p53. Indeed loss of p53 function is reported in more than 50% of the human 
cancers. p53 is mainly regulated at the protein level by ubiquitylation catalysed 
by E3 ubiquitin-ligase MDM2 which induces p53 degradation. We found GMPS 
as a major player in the regulation of p53 stability upon various cellular stresses. 
GMPS stabilizes p53 by forming a complex with the deubiquitilase USP7. GMPS 
predominantly resides in the cytoplasm in unstressed cells but translocates into 
the nucleus upon induction of stress and stabilizes p53 through USP7-mediated 
deubiquitylation. GMPS acts as a sensor of the cellular nucleotide pool and activates 
the p53-mediated replicative stress response to the nucleotides depletion. GMPS 
nuclear exclusion is regulated by mono-ubiquitylation mainly catalyzed by the 
E3 ubiquitin-ligase TRIM21. Thus, TRIM21 negatively regulates p53 stability by 
preventing GMPS nuclear translocation. Upon induction of stress, GMPS dissociates 
from TRIM21 and translocate into the nucleus where it is deubiquitinated by 
USP7. Thus, monoubiquitylation forms a switch which controls GMPS sub-cellular 
localization and determines p53 stability. Therefore, TRIM21-GMPS-USP7 forms a 
novel regulatory circuit of the tumor suppressor p53 stabilization pathway.
Chapter 3 describes the purification and functional characterization of the 
Drosophila NuRD complex. NuRD is one of the four major ATP-dependent chromatin 
remodeling complexes, which regulates chromatin structure and gene expression. 
The subunit composition of the remodeling complex determines its functional 
specificity by targeting to different chromatin loci. We identified MEP1 and DOC1 
as bona fide subunits of the Drosophila NuRD complex. In addition, we found 
transcription factor Tramtrack69 (TTK69) as a NuRD interacting protein. TTK69 has 
been implicated in various aspects of Drosophila development, such as neuronal 
differentiation and photoreceptor and tracheal development. TTK69 interacts with 
the NuRD complex via the MEP1 subunit. TTK69 binds to promoters of target genes 
and recruits the NuRD complex to establish transcriptional repression. Therefore, 
there appears to be a hierarchical relationship in which transcription factor binding 
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precedes chromatin remodeler recruitment. Thus, TTK69 and the NuRD complex 
participate together in gene expression control. 
Chapter 4 describes the gene regulatory network of human DOC1. DOC1 
is a potential tumor suppressor protein that is found deleted or down regulated in 
several cancers. Re-expression of DOC1 in deleted oral cancer cell lines results in cell 
growth inhibition. The cell growth inhibitory effect of DOC1 has been attributed to 
inhibition of CDK2-mediated cell proliferation. Apart from CDK2 regulation, DOC1 
has also been identified as a subunit of the NuRD complex. However, the precise 
mechanism of tumor suppression by DOC1 through gene regulation is not well 
understood. Proteomic analysis of DOC1 associated proteins identified SMAD4, an 
intracellular mediator of the TGF-b signalling, as a DOC1 interacting protein. RNAi-
mediated depletion of DOC1 and CHD4 (ATPase subunit of NuRD) results in the 
de-repression of SMAD4 target genes. Therefore, our preliminary results suggest 
that DOC1 together with the NuRD complex functions as an inhibitor of TGF-b 
target genes which are involved in promoting cell proliferation, EMT (epithelial-
to-mesenchymal transition), metastasis and angiogenesis. However, additional 
research is warranted to better understand the role of DOC1 in gene regulation. 
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Nederlandse Samenvatting
Gereguleerde genexpressie is essentieel voor de normale groei en ontwikkeling van 
een organisme. Verandering in genexpressie door verkeerde lokalisatie, deletie, of 
degradatie van belangrijke transcriptiefactoren of chromatine regulators kan leiden 
tot veranderingen in de cellulaire fysiologie, wat uiteindelijk weer kan resulteren 
in ontwikkelingsstoornissen en ziektes. Begrip van genregulatiemechanismes is 
daarom essentieel voor het ontdekken van therapeutische doelen.
In hoofdstuk 2 wordt de rol van het metabolische enzym GMPS in de 
regulatie van de stabiliteit en functie van p53 beschreven. Stabilisatie van p53 is 
essentieel voor de cellulaire aanpassing aan stress. Als gevolg van verschillende 
cellulaire stresssignalen wordt p53 gestabiliseerd, waarna p53 de expressie van 
genen reguleert die betrokken zijn bij de controle van de celcyclus, apoptose, 
senescentie en celmetabolisme. Hieruit volgt dat bij afwezigheid van p53, cellen 
een aanzienlijk groeivoordeel hebben. Er is inderdaad gerapporteerd dat er in 50% 
van de humane kankers verlies van p53 functie is. p53 wordt voornamelijk  op 
eiwitniveau gereguleerd door ubiquitylering, wat wordt gekatalyseerd door het E3 
ubiquitine-ligase MDM2. Dit leidt tot degradatie van p53. Wij hebben ontdekt dat 
GMPS een belangrijke speler is in de regulatie van p53 stabiliteit na verscheidene 
cellulaire stresssignalen. GMPS stabiliseert p53 door, als gevolg van stress, een 
complex te vormen met het deubiquitylase USP7. In niet-gestresste cellen zit GMPS 
voornamelijk in het cytoplasma, maar na inductie van stress verplaatst het naar de 
kern en stabiliseert het p53 via deubiquitylering door USP7. GMPS werkt als een 
sensor van de cellulaire nucleotide voorraad en activeert de p53-afhankelijke stress 
respons na nucleotide depletie. Wering uit de kern van GMPS wordt gereguleerd 
door monoubiquitylering, wat voornamelijk wordt gekatalyseerd door het E3 
ubiquitine ligase TRIM21. Hieruit volgt dat TRIM21 de stabiliteit van p53 negatief 
reguleert door de verplaatsing van GMPS naar de kern te verhinderen. Bij stress 
inductie dissocieert GMPS van TRIM21 en verplaatst het naar de kern waar het wordt 
gedeubiquityleerd door USP7. Aldus vormt monoubiquitylering een schakelaar die 
de subcellulaire lokalisatie van GMPS reguleert en de stabiliteit van p53 bepaalt. 
TRIM21-GMPS-USP7 vormt daarom een nieuw regulerend circuit in de stabilisatie 
route van de tumor suppressor p53.
Hoofdstuk 3 beschrijft de zuivering en functionele karakterisering 
van het Drosophila NuRD complex. NuRD is één van de vier belangrijke ATP-
afhankelijke chromatine remodellerende complexen, wat de chromatine structuur 
en genexpressie reguleert. De samenstelling van de subeenheden van het 
remodellerende complex bepaalt zijn functionele specificiteit door binding aan 
verschillende chromatine loci. Wij hebben MEP1 en DOC1 geidentificeerd als 
bona fide subeenheden van het Drosophila NuRD complex. Bovendien vonden we 
dat transcriptiefactor Tramtrack69 (TTK69) een NuRD bindend eiwit is. TTK69 is 
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geacht betrokken te zijn bij verscheidene aspecten van Drosophila ontwikkeling, 
zoals neuronale differentiatie, en fotoreceptor- en tracheale ontwikkeling. TTK69 
bindt aan het NuRD complex via de MEP1 subeenheid. TTK69 bindt aan de 
promotors van specifieke genen en trekt het NuRD complex aan, wat leidt tot 
transcriptionele repressie. Bijgevolg blijkt er een hiërarchische relatie te bestaan, 
waarin transcriptiefactor binding vooraf gaat aan trekking van de chromatine 
remodelleerder. Aldus werken TTK69 en het NuRD complex samen in genexpressie 
regulatie.
Hoofdstuk 4 beschrijft het genregulatie netwerk van het humane DOC1. 
DOC1 is een mogelijk tumor suppressor eiwit, wat gedeletet, of omlaag gereguleerd 
is in verscheidene tumoren. Herexpressie van DOC1 in deleted oral cancer cellijnen 
leidt tot remming van celgroei. Dit effect van celgroeiremming door DOC1 wordt 
toegewezen aan de inhibitie van CDK2-afhankelijke celproliferatie. Afgezien 
van zijn rol in CDK2 regulering is DOC1 ook geïdentificeerd als een subeenheid 
van het NuRD complex. Het precieze mechanisme van tumor suppressie door 
DOC1 via genregulatie wordt nog niet goed begrepen. Proteomische analyse 
van DOC1-geassocieerde eiwitten leidde tot de identificatie van SMAD4 als een 
DOC1-bindend eiwit. SMAD4 is een intracellulair regeleiwit van TGF-β-afhankelijke 
signaaltransductie. RNAi-afhankelijke depletie van DOC1 en CHD4 (een ATPase 
subeenheid van het NuRD complex) resulteert in de derepressie van SMAD4 
gereguleerde genen. Onze voorlopige resultaten suggereren derhalve, dat DOC1, 
samen met het NuRD complex, functioneert als een remmer van TGF-β gereguleerde 
genen, welke betrokken zijn bij de stimulering van celproliferatie, EMT (epitheel 
naar mesenchyme transitie), metastase, en angiogenese. Echter, verder onderzoek 
is noodzakelijk om de rol van DOC1 in genregulatie beter te begrijpen.
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ALDH4 Aldehyde dehydrogenase 4
AMP Adenosine monophosphate
BMP Bone morphogenetic protein
BTB-POZ BR-C, ttk and Bab – Poxy virus and Zinc finger
CDK2NA Cyclin-dependent kinase inhibitor 2A
Daxx  Death-domain associated protein
DEC1 Deleted in esophageal cancer 1
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DRAM  Damage-regulated autophagy modulator
EBNA1  Epstein-Barr nuclear antigen 1
GADD45  Growth Arrest and DNA Damage 45
GMAT Guanidinoacetate methyltransferase
GMP Guanosine monophosphate
GMPS  Guanosine monophosphate synthetase
GPX1 Glutathione peroxidase 1
HAUSP Herpes-simplex virus associated ubiquitin specific protease
ICP0  Human Herpes Virus Infected Cell Polypeptide 0
IMPDH  Inosine-5’-monophosphate dehydrogenase
IRF Interferon regulatory factor
MDM2 Murine double minute 2
MEP1 Mog-interacting and ectopic P-granules 1
NuRD Nucleosome remodeling and deacetylase
NQO1 NAD(P)H: quinone oxidoreductase 1
PAI-1 Plasminogen activator inhibitor-1
PGM  Phosphoglycerate mutase
PML Promyelocytic leukemia protein
SCO2  Synthesis of Cytochrome C Oxidase 2
SMAD SMA and MAD related family                      
SSA 1 Sjogren’s syndrome autoantigen 1
TGF-b  Transforming growth factor - beta
TIGAR  TP-53- induced glycolysis and apoptosis regulator
TNF Tumor necrosis factor
TRIM21 Tripartite motif 21
TTK69  Tramtrack 69
Ubl Ubiquitin-like domain
USP7 Ubiquitin specific protease 7
USP10  Ubiquitin specific protease 10
USP11  Ubiquitin specific protease 11
XMP Xanthosine monophosphate
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